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Summary 
 
Streptococcus uberis is a leading cause of mastitis worldwide with significant financial and 
welfare implications.  It is uncontrolled by present disease control strategies and further 
knowledge of the interactions between host and pathogen are crucial to permit the 
development of novel control strategies. 
 
Neutrophils (PMNs) migrate into the udder in large number and they are responsible for 
removing other udder pathogens.  However previous work has shown that virulent S. uberis 
0140J releases an unidentified soluble factor that inhibits the bactericidal activity of PMNs.  
This work set out to elucidate a better understanding of this host-pathogen interaction; firstly 
by investigation to determine whether avirulent strains of S. uberis were killed by PMNs, and 
secondly by assessing transcriptional changes between PMNs after exposure to milk and  milk 
in which S. uberis has been cultured by microarray analysis.   
 
Naturally occurring and mutant strains of S. uberis that show attenuation in the host were 
unaffected by the presence of functional PMNs, indicating that their attenuation in the host 
cannot be attributed to increased susceptibility to the bactericidal activities of PMNs. 
 
PMNs incubated in milk in which S. uberis 0140J had been cultured (ST PMNs) had an altered 
transcriptome compared to PMNs incubated in milk.  Genes involved in cell death and the 
inflammatory responses appear effected.  A down-regulation of pro-apoptotic genes was 
observed, this finding was supported by a highly significant reduction in the presence of 
apoptotic cells, compared to cells incubated in milk. Transcription of pro-inflammatory 
cytokines LQFOXGLQJ &;&/ ,/ȕ DQG CCL20 was up-regulated in ST PMNs and genes 
involved in cellular structure and metabolism had altered levels of expression.  This data from 
this investigation has provided an initial insight into the mechanisms by which S. uberis may 
elicit changes in PMNs that may relate to inhibition the bactericidal function and/or other host 
pathogen interactions. 
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1.1 The Importance of Bovine Mastitis 
 
Bovine mastitis, inflammation of udder, is a significant problem for the UK and world dairy 
industry.  It has been estimated to be the most economically significant infectious disease of 
dairy cattle (Kossaibati and Esslemont, 1997), costing the dairy industry £200 billion 
worldwide and the UK around £200 million annually (Biggs, 2009).  The disease also has 
major welfare implications; in 2009 the Farm Animal Welfare Council recommended that the 
incidence of mastitis should urgently be reduced (FAWC, 2009).  
 
Mastitis is usually associated with the presence of an infectious agent.  A large number of 
microbial agents come into contact with the udder and have the opportunity to enter the 
mammary gland via the teat canal; nevertheless  most clinical mastitis cases are caused by only 
five causative bacteria: Streptococcus uberis, Staphylococcus aureus, Streptococcus 
agalactiae, Streptococcus dysgalactiae and Escherichia coli  (Bradley, 2002) giving some 
indication of the multiple host and pathogen factors required to establish infection.   
 
Classical, infectious mastitis is defined by two parameters. Firstly by severity: in a subclinical 
case the cow shows no obvious outward signs of disease and the bacterial infection can 
become chronic. Clinical cases show adverse changes in the milk, the udder can be hot, 
swollen and painful, and as the severity of the case increases the cow becomes less productive, 
systemically unwell and in some cases can progress to septicaemia and death.  Secondly, 
infections are classified based on whether the source of infection is either environmental or 
contagious.  Although these definitions are quite arbitrary, they are still a useful starting point.  
Contagious pathogens, typically S. aureus and S. agalactiae, are found in the udder or on the 
udder or teat surface, and do not survive well in the environment.  Infection is spread from one 
cow to another animal either directly or more usually via fomites during milking.  On the other 
hand, pathogens that are considered environmental pathogens are those acquired from the 
FRZ¶s surroundings - from pasture, bedding and faecal material, where the bacteria persist 
well.  Pathogens from the environment do not need to inhabit the bovine udder and cause 
disease for their survival.  S. uberis and E. coli are typically classed as environmental 
pathogens.   
 
The Five Point Plan outlining basic hygiene, husbandry, preventative measures and treatments 
for mastitis control has been universally implemented since the late 1960s (Bradley, 2002).   
This resulted in a dramatic decrease of mastitis due to contagious pathogens, which accounted 
for the vast majority of isolates (Wilson and Brookbanks, 1967). Intramammary infection by 
environmental pathogens was not controlled by these activities, and this has been reflected in 
the subsequent relative increase in their prevalence (Bradley et al., 2007, Bradley, 2002, 
Booth, 1997).   Surveys suggest that environmental pathogens account for over 60% of cases 
(Bradley and Green, 2001, Bradley et al., 2007) and also indicate a possible increased 
incidence of mastitis in the past 10-20 years (Bradley et al 2007). 
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1.2  The Ubiquitous Nature of S. uberis 
Many strains of S. uberis have been identified from the environment and from cases of clinical 
mastitis.  The strain 0140J occurs within the sequence type 5 (ST-5 ) clonal complex, the 
sequence type  most frequently associated with disease-causing strains in the UK (Coffey et 
al., 2006).  S. uberis 0140J was first isolated from a clinical case of mastitis in the 1970s.  This 
strain  reproducibly infects and causes disease in the lactating gland (Leigh et al., 1990, 
Bannerman et al., 2004a), and has also been shown to cause disease in the non-lactating 
mammary gland (Hill, 1988).  It has been used extensively worldwide to research the 
pathogenesis of S. uberis, and is the organism of choice for this project. 
 
Mastitis caused by S. uberis is traditionally associated, in the UK, with housed cattle, 
especially those kept on straw.  Straw has been shown to support higher S. uberis populations 
compared to wood-derived bedding (Hogan et al., 1989, Rendos, 1975).  Although inorganic 
bedding (i.e. sand) has been reported to support lower bacterial numbers,  the bacterial load 
increases with  increasing organic contamination (Hogan et al., 1989).  Pasture based systems 
are also associated with mastitis caused by S. uberis (Compton et al., 2007), with bacterial 
populations reaching levels comparative to that within housed farming systems (Harmon, 
1992).   S. uberis is found in the gastrointestinal tract of healthy cows and excreted in the 
faeces into the environment where it can survive for two weeks (Lopez-Benavides et al., 
2007).    This ability to survive outside the host, its presence in all farming systems and the 
ineffectiveness of the Five Point Plan in controlling it makes S. uberis a formidable pathogen, 
relevant to the dairy industry worldwide.   
 
1.3 The Immune Response to Mastitis Pathogens 
The bovine udder has an armoury of defences against invading pathogens; indeed it has been 
suggested that the mammalian mammary gland evolved as a secretory gland of the primitive 
immune system that produced a protective secretion, developing its nutritional function for 
supporting the neonate later (McClellan et al., 2008, Vorbach et al., 2006).   
 
1.3.1 Physical Defences of the Mammary Gland 
The streak canal, at the distal end of the teat, forms an initial barrier against invading 
pathogens.  When the udder is not under a physiological state for milk let-down, the orifice is 
closed by constriction of sphincter muscles. It is only relaxed as part of the cascade of effects 
that oxytocin, released in response to stimulation by the calf or the routine of coming into the 
milking parlour, causes to result in milk-let-down.  An additional crucial defence is the keratin 
plug which is formed from the constant turnover of the stratified squamous epithelial lining of 
the streak canal.  The plug forms during the dry period and between milkings, and acts as a 
physical and bactericidal obstacle to invading pathogens.  In some individuals the competency 
of these protective mechanisms can be low, increasing the likelihood of pathogens invading 
past the teat canal into the teat cistern. For example, closure of the end of the teat can be 
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inherently poor or damaged, due to over-milking or infection and in some individuals an 
effective keratin plug is not formed. 
 
Where the streak canal meets the teat cistern, the lumen of the teat, is the anatomical formation 
known as the Rosette of Fürstenburg encircling the top of the streak canal.  This non-muscular 
structure is formed by deep folds of the cuboidal epithelium that lines the teat cistern and is 
continuous with the rest of the epithelia of the mammary gland itself.   It is thought that the 
folds of this structure produce a large surface area of the epithelium allowing leukocytes to 
rapidly access the area to defend against pathogens. 
 
1.3.2 Cellular and Humoral Defences of the Mammary Gland 
If microbes manage to penetrate past the streak canal, and into the mammary gland itself, then 
specific motifs associated with pathogens, so-called pathogen associated molecular patterns 
(PAMPs) are identified by pattern recognition receptors (PRRs) on mammary epithelial cells 
(MEC) and resident sentinel leukocytes.  Toll-like receptors (TLRs) are a family of PPRs that 
recognise specific bacterial components, for example lipopolysacharide (LPS), peptidoglycan 
and lipoteichoic acid.  Pathogen detection activates signalling cascades which result in the 
production of cytokines by the host cells (Lahouassa et al., 2007, Bannerman et al., 2004b), 
some are potent chemoattractants causing the influx of circulating leukocytes into the udder.   
Blood polymorph nuclear cells (PMNs) rapidly diapedese and enter into the udder in high 
numbers, this is seen clinically as a rise in somatic cell count (SCC). The key function of 
PMNs is to identify and remove pathogens by phagocytosis, this is a crucial step in defence of 
the mammary gland and highly effective against a variety of bacterial species (Hill et al., 1978, 
Schalm et al., 1976). Circulating monocytes are slower to enter into the udder; they mature 
into macrophages and also remove pathogens and importantly dead and dying PMNs from the 
milieu. If the infection persists despite this response T and B lymphocytes and monocytes 
increase.  The role of lymphocytes in the response to mastitis is less well defined.  T cell 
response populations in the non-lactating gland are primarily CD4+ (helper) dominated 
(Mehrzad et al., 2008, Asai et al., 1998).  CD8+ cells become predominant during lactation 
(Asai et al., 1998) and in early E. coli infection (Mehrzad et al., 2008). 
 
The udder also has a host of humoral protective mechanisms including adaptive antibody (Ab) 
and non-adaptive molecules including xanthine oxidase, lactoferrin, complement and 
lysosyme, all which may have an antibacterial role against the invading pathogen. 
 
Opsonisation is an important step in early pathogen recognition and the importance of 
complement and different Ab are not fully defined.  IgG1, important for protection of the 
neonate, is selectively transferred from the bovine circulation into the udder and is the 
principal Ab found in normal milk, but has low opsonic activity.  Levels of IgG2 rapidly 
increase in the udder at the onset of infection, IgG2 is a potent opsonin and rapidly becomes the 
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predominant Ab (reviewed Burton and Erskine, 2003). Activated PMNs in the udder have up-
regulated expression of pathogen linked IgG2 Fc receptors, leading to rapid pathogen clearance 
:RUNX HW DO  =DQJ HW DO  $E DOVR ELQGV WR EDFWHULD GHFUHDVHV WKH SDWKRJHQV¶
ability to adhere to tissue.   
 
The importance of IgM and complement are less defined. Although complement acts as an 
opsonin for mastitis pathogens, its actions are inhibited by milk.  IgM requires complement 
activation to augment is opsonic capabilities but some work shows IgM to be a key opsonically 
active molecule in the udder (Williams and Hill, 1982).  The IgM are thought to be primarily 
³QDWXUDO DQWLERGLHV´ ZKRVH SUHVHQFH LV DV HQGRJHQRXV $E and not the result of previous 
exposure to exogenous stimuli (Rainard and Riollet, 2006). 
 
A multitude of pathogen and host factors determine the success of the immune response.  This 
project aims to focus on the contribution of PMNs to the innate immune response of the bovine 
mammary gland during infection. 
 
The pathology induced in a case of bacterial mastitis is as much due to the response of the 
immune system as it is to the pathogen itself.  PMNs contain highly cytotoxic granules and via 
enzymatic degradation and the production of reactive oxygen species have been shown to 
induce tissue damage (Ledbetter et al., 2001, Zhao and Lacasse, 2008).  Further understanding 
of how the interactions between pathogen and host influence the extent of pathology is 
required.  Immunomodulatory therapies are a novel focus of research (Inumaru, 2010, 
Wedlock et al., 2008) aimed at limiting the negative effects of mastitis.  Knowing which 
aspects of the immune response are appropriate or over-reactive would aid in targeting the 
development of potential immunomodulatory therapies which could enhance a specific 
response or dampen down an over exuberant one (Lauzon et al., 2005). 
  
 12 
 
1.3.3 The Structure and Function of PMNs 
PMNs are the principal cell type seen in the classical defined innate immune response, and the 
term is used interchangeably with neutrophils, although the PMN classification can also 
include eosinophils and basophils.  In the bovine between 15-45 % of circulating leukocytes 
are PMNs (Kahn, 2005).  In other species, they generally have a higher representation; for 
example in humans PMNs account for 35-80% of circulating leukocytes (Kumar, 1999).   
 
Mature and circulating PMNs have been historically thought of as having very limited 
transcriptional potential and that their sole function was to phagocytose and kill foreign 
pathogens.  This response was considered non-specific and a rather clumsy but effective first 
line defence.  With the advancement of genome-wide and post-genomic studies this view is 
changing.  The interaction of PMN and pathogen is complex and the response pathogen-
specific.  PMNs¶ ability to direct the course of both the innate and adaptive arms of the 
immune response is now a focus of research (Nathan, 2006, Whale and Griebel, 2009).  
Activated neutrophils undergo a burst of transcriptional activity of inflammatory related genes 
after migration to sites of inflammation,  influencing other immune cells (Borregaard et al., 
2007) and hence the progression of disease and tissue healing.  Neutrophils, like specialized 
antigen presenting cells (APCs), are able to take up MHC class II from apoptotic and necrotic 
cells and can act as APCs (Whale et al., 2006a), capable of stimulating bovine T cells (Whale 
et al., 2006b) and dendritic cells in the murine model (Tateda et al., 2001).  Clearly, PMNs, 
through interactions with other cells contribute dynamically to the overall progression and 
resolution of the inflammatory response.  Further understanding of the PMN-pathogen 
interactions is important in elucidating the pathogenesis of infectious disease. 
 
PMNs are produced in bone marrow in the myelopoietic tissue of the bone marrow.  In a 
quiescent state, they continue to reside in the myeloid tissue for 7-10 days, and then enter the 
circulation where they are short lived (half-life 8.9 hours) (Carlson and Kaneko, 1975).  Some 
sentinel PMNs enter tissue and, if unstimulated apoptose within 24-48 hours.   Their high 
circulating density allows large numbers to influx into stimulated tissues, with their multi-
lobed nuclei affords them the flexibility to move swiftly through endothelial tight junctions. 
 
1.3.4 Mechanisms of Microbial Actions of PMNs 
The role of PMNs and their mechanisms of pathogen elimination has been extensively 
reviewed (Segal, 2005, Paape et al., 2003, Hampton et al., 1998). These key cells identify 
pathogens via receptor-mediated recognition, engulf them to form a phagosome and then fuse 
with cytoplasmic granules, exposing the pathogen to their cytotoxic contents (Fig 1).  
Bovine PMNs contain three types of cytoplasmic granules.  Azurophilic granules mediate 
bacterial killing via the myleoperoxidase-hydrogen peroxide-halide system.  Specific 
(secondary) granules contain lactoferrin and other antimicrobial compounds.  Novel granules 
identified in domesticated ruminants (Gennaro et al., 1983), are the predominant granule seen 
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in mature bovine neutrophils.  Novel granules appear unique to ruminants and are distinct from 
tertiary granules found in other species, i.e. humans (Dewald et al., 1982).  They are the sole 
store for  defensins and bactenecins ± highly cationic proteins; and, like other granules, they 
also contain lactoferrin.  
 
Human PMNs were discovered to produce Neutrophil Extracellular Traps (NETs), a potent 
bactericidal web-like structure thrown out by PMNs, after which the cell is dead.  NETs 
consist of chromatin fibres adorned with histones and cytoplasmic granule contents, including 
elastase, cathepsin G, myleoperoxidase (1º granules) and lactoferrin (2º granules) (Brinkmann 
et al., 2004).  NET formation has now been seen in several animal species including the mouse 
(Ermert et al., 2009) and cow (Grinberg et al., 2008).  The importance of NETs is indicated by 
studies of human Chronic Granulomatous Disease.   Affected individuals, with no, or very low 
levels, of NADPH oxidase activity (Heyworth et al., 2003) are unable to produce Reactive 
Oxygen Species (ROS), and work suggests that they are also unable to produce NETs. 
Supported by other evidence, this suggests that NETs are a sequel to ROS generation.  
However, in cattle, work has shown that whole milk inhibits ROS production and phagocytic 
function of PMNs compared to blood isolated cells but not the ability to form NETs (Lippolis 
et al., 2006). 
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Fig 1. PMN Structure 
 
Structure of PMN and important receptors.  Inset (a) CD11/CD18 cell surface receptors bind to ICAM receptors on the endothelium triggering adhesion and 
diapedesis.  (b)  Pathogen recognition mediated by cell surface receptors.  Pathogens are subsequently taken up into a phagosome which fuses with cytoplasmic 
granules and the pathogen is exposed to their cytotoxic contents.  (c) Fatigued PMNs express surface receptors identifying themselves for uptake by scavenging 
macrophages. 
 
(a) 
(c) 
(b) 
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1.3.5 PMN Cell Death 
The principal mechanisms of cell death are necrosis and apoptosis, although NET formation 
should probably also be classified as a recognised form of cell death which has been termed by 
some as ³NETosis´ (Brinkmann and Zychlinsky, 2007).  During apoptosis (programmed cell 
death) the cell membrane remains intact.  This contrasts with necrosis where cell death is 
mediated via cell lysis.  Apoptotic neutrophils attract macrophages, and via the macrophage 
vitronectin receptor (Savill et al., 1990) are identified and phagocytosed.  This promotes 
resolution of inflammation and tissue healing firstly by preventing the release of the 
QHXWURSKLOV¶F\WRWR[LFFRQWHQWVDQGVHFRQGO\by leading to up-regulation of anti-inflammatory 
pathways in the macrophages (Fox et al., 2010).    Modulation of PMN apoptosis by the human 
pathogen Streptococcus pyogenes to further its own survival has been recognised (Kobayashi 
et al., 2003).  Human neutrophil functionality (motion, phagocytic ability and chemotaxis) 
decreases in apoptotic populations.  (Whyte et al., 1993). 
 
1.4 Streptococcus uberis Pathogenesis 
 
1.4.1 Virulence Determinants of S. uberis  
S. uberis 0140J, a virulent strain, was originally isolated from a clinical case of bovine mastitis 
in 1973.  Multilocus sequence typing (MLST) has shown that 0140J falls within the ST-5 
clonal complex, the major lineage associated with cases of mastitis in the UK (Coffey et al., 
2006).  Furthermore, it reliably produces clinical disease in both lactating (and non-lactating) 
animals, making experimental findings pertinent to on-farm disease.   
 
In an established bovine intramammary infection model, despite a large influx of PMNs into 
the udder, no phagocytosis of S. uberis 0140J by PMNs was identified (Thomas et al., 1994) 
although the bacteria were taken up by macrophages (Grant R.G, 1996).  S. uberis 0140J 
inhibited the phagocytic function of bovine PMNs and avoided being taken up (Field et al., 
1997).  The ability to evade the early host immune response and establish infections is 
characteristic of streptococcal disease in both humans and animals, and the mechanisms by 
which this is achieved are varied and not fully elucidated. 
 
S. uberis EF20 is an avirulent field strain isolated from a cow in the late 1970s (J.A. Leigh, 
personal communication). The animal was reportedly clinically infected but all lactating 
animals challenged with the strain since reproducibly show only mild or no disease (Hill, 
1988). 
 
S. uberis 0145m, and 1095m are mutants generated from 0140J by random insertional 
mutagenesis and sub1154m is a deletion mutant generated by allelic exchange mutagenesis 
(Leigh et al 2010).  These mutants have disrupted expression of surface proteins associated 
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with virulence and each shows an attenuated phenotype in lactating cattle, although the precise 
mechanisms underlying the attenuation in each case are unknown. 
 
The cell surface of bacteria is covered with various protruding macromolecules, the attachment 
of which to the underlying peptidoglycan wall is facilitated by enzyme attachment.  The 
transamidase SortaseA (SrtA) has been shown to be important in covalently attaching some 
proteins that may act as virulence determinants (Mazmanian et al., 1999, Lalioui et al., 2005, 
Comfort and Clubb, 2004) .  Following experimental infection the insertional mutant of S. 
uberis 0140J that lacked the SrtA gene initially colonised the bovine udder to a similar 
bacterial load as the wild type, but was unable to continue to colonise to a greater extent.  
Infection with the mutant induced a similar SCC, but without clinical signs of mastitis. Ten 
surface proteins on S. uberis 0140J have been identified to be anchored by SrtA (Egan et al., 
2010). Individual insertional / deletion mutants in which each of the genes encoding these 
proteins were disrupted were produced and used in a similar challenge study.  Three of these 
lacking  sub0145 ± a lactoferrin binding protein, sub1095 - a collagen-like protein and sub1154 
± serine protease with limited homology to C5a peptidase,  were shown to be required for full 
expression of virulence (Leigh et al., 2010).   
 
In addition, a mutant of S. uberis 0140J lacking a gene regulator protein known as virulence 
regulator uberis (Vru) has been assessed in vivo and shown to  cause  only very  mild signs of 
disease (Leigh et al., unpublished). Whether the attenuation of any of these strains was due to 
enhanced clearance through the bactericidal action of PMNs was not investigated. 
 
The human pathogen Streptococcus pyogenes (Group A Streptococci, GAS)  produces a C5a 
peptidase which, via complement degradation, limits recruitment of complement activated 
PMNs, (Ji et al., 1996).  It uses this, in addition to other mechanisms (Voyich et al., 2004), to 
circumvent the immune system and establish an infection.  Knowledge of S. uberis virulence 
determinants and their role in pathogenesis may parallel and augment our understanding of 
other streptococcal diseases.   
 
1.4.2 S. uberis in the Cow 
Studies into how S. uberis isolates behave in vivo has focused on various aspects of the 
immune response, utilizing a diverse range of strains, animal factors and experimental design 
(Bannerman et al., 2004a, Hill, 1988, Moyes et al., 2009).  However, the non-uniformity across 
studies makes it difficult to compare these and severely limits extrapolation from one study to 
another.    
 
In experimental infection the strain UT888, reached peak bacterial numbers of 105 cfu ml-1 
72hr post infection (p.i) in second lactation heifers, 11-38 days in milk, with clinical signs of 
mastitis observed 12hr after this.  In this experiment, concentrations of CXCL8, IL-ȕ DQG 
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71)ĮLQWKHZKH\ZHUHPHDVXUHGDQGVKRZQWRKDYHLQFUHDVHGVLJQLILFDQWO\E\KRXUVSL
(Rambeaud et al., 2003).  By comparison, strain 0140J in lactating heifers reproducibly reaches 
a peak of 107 cfu ml-1 at  24hrs  p.i., bacterial numbers remain elevated and animals require 
treatment 3-4days p.i. (Leigh et al., 1990).  CXCL8 was shown to peak at 36 and again at 72hr 
p.i., whilst IL-1 ȕDQG71)ĮOHYHOVFRQWLQXHGWRLQFUHDVHIURP 30hr p.i. until the end of the 
experiment at 7days p.i. (Bannerman et al., 2004a). The variety of bacterial strains, 
experimental design and the parameters measured prohibits assuming the findings of one study 
are applicable under slightly different experimental conditions. 
 
1.4.3 Hosts Effects on the Pathogenesis of Mastitis 
Anecdotally, the breed of cow is often associated with differences in susceptibility to mastitis.  
A study by Rambeaud et al., in 2003 used a mixed population of Jersey and Holstein cows, and 
although it was not designed primarily to compare the breeds, no differences were observed.  
In vivo studies with S. aureus and E. coli looking for breed differences between Jerseys and 
Holsteins showed no significant differences in disease progression and cytokine profiles 
(Bannerman et al., 2008a, Bannerman et al., 2008b).  However, in response to S. aureus 
Holsteins showed a higher circulating level of PMNs, though this did not translate into a 
higher SCC. Body weights are not mentioned, yet given the large body frame of most 
Holsteins it could be hypothesised that this reflects the greater amount of myelopoietic tissue 
and therefore larger reservoir of neutrophils which, when stimulated, enter the circulation.  In 
Jerseys cytokine expression appeared slightly prolonged, and although this had no influence on 
disease it may be associated with longer suppression of milk yield following infection.   
Despite widely reported differences in breed susceptibility to mastitis (Youngerman et al., 
2004, Berry et al., 2007) these data indicate that it may be GXHWRIDFWRUVRWKHUWKDQWKHKRVWV¶
immune response. Together with the fact that the majority of the UK herd is Holstein based 
this implies that using the Holstein Friesian for future projects is a relevant model.   
 
Within breeds, breeding for trait has also suggested a genetic basis to disease susceptibility.  A 
recent study showed significant transcriptional differences in primary cell cultures, from cells 
isolated from German Holsteins predicted to be resistant or susceptible to mastitis based on the 
presence of a QTL associated with mammary health (Gunther et al., 2009). 
 
Feeding dairy cows to meet their nutritional requirements and the metabolic demands of milk 
production is crucial to maintain their health.  Mastitis cases peak in the first 11 weeks of 
lactation (Biggs, 2009), when animals are metabolically (and in some systems socially) most 
stressed.  Negative energy balance (NEB) is caused by inadequate energy intake due to poor 
ration formulation, poor access to feed or concurrent disease limiting feeding activity.   NEB 
has been shown to affect the transcriptional expression of TLR receptors and cytokines of 
neutrophils when challenged with intramammary S. uberis  (Moyes et al., 2010a) although 
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clinical differences were not recorded.  An unspecified feed additive is reported to also be 
associated with neutrophil apoptosis regulation (Wang et al., 2009) . 
 
1.4.4 Long term and Systemic Effects of Mastitis   
Acute cases of mastitis are often associated with a 5% decrease in milk yield for the whole 
lactation and in cases which are not cured rapidly, a prolonged infection and decrease in 
productivity (Seegers et al., 2003).  Histological changes in mammary epithelium  as a 
consequence of disease are seen (Zhao and Lacasse, 2008).  Six days after inoculation with S. 
uberis 0140J changes consistent with early stage fibrosis were observed (Thomas et al., 1994).   
Work reviewed recently (Singh et al., 2010) indicates that E. coli and S. uberis intramammary 
infections can result in epigenetic, and even genomic, modification.  Therefore, even epithelial 
tissue, although  not histologically changed, may be less productive even after the infection has 
cleared.  
 
The direct effect of the infection and also the often underestimated effect of pain on 
productivity (Huxley and Whay, 2006) have systemic consequences.  Release of acute phase 
proteins is seen in response to mastitis-affected animals (Horadagoda et al., 1999), including  
cases due to  S. uberis (Bannerman et al., 2004a) and sub-clinically infected animals (Gerardi 
et al., 2009).  After intra-mammary challenge with E. coli, WKH OLYHU¶V WUDQVFULSWLRQDO SURILOH
alters (Jiang et al., 2008), supporting the need for a holistic approach when considering the 
consequences of an intramammary infection. 
 
1.4.5 Microarray Analysis of S. uberis Mastitis Models 
Multiple cell types are present and involved during infection of the bovine mammary gland.  
Studies highlighting the transcriptional response of the udder as a whole give an indication of 
inflammatory pathways involved (Moyes et al., 2009, Moyes et al., 2010a) but do not assess 
the contribution of specific cell populations.  This knowledge is required to enable targeting of 
specific steps in the infection process to prevent progression of harmful inflammatory paths 
and encourage resolution of disease.  Lactating cows in either a positive or negative energy 
balance were experimental challenged with S. uberis and the transcriptome of udder biopsies 
(Moyes et al., 2009, Moyes et al., 2010b) and circulating PMNs assessed (Moyes et al., 
2010a).  This work shows that within the mammary gland genes associated with immune 
function are differentially expressed in infection. 
 
Comparing the transcriptome of the mammary gland and primary mammary epithelial cell 
cultures after challenge with S. uberis indicated that changes in immune gene expression in 
mammary epithelium is dependent on the presence of other cell types and their interactions 
(Swanson et al., 2009).  Further insight into how individual cell populations may contribute to 
the immune response of the bovine mammary gland are required. 
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1.5 Hypothesis and Project Aims 
Given the socio-economic and animal welfare implications of S. uberis mastitis within the 
dairy industry there is currently a major drive to understand the important host factors 
governing disease onset, disease outcome and resistance to infection. In tandem, work is 
currently underway to assess cell surface molecules of S. uberis as virulence determinants and 
to investigate subsequent knock-on effects during intra-mammary infection (reduced 
colonisation, decrease in clinical signs, altered innate immune response).  
 
 
1.5.1 Hypothesis  
The work presented herein seeks to address the hypothesis that the secretome of S. uberis 
strains of differing virulence will affect the survival, bactericidal actions and gene transcription 
of bovine PMNs.  
 
 
1.5.2 Project aim 
The project undertaken and reported here was focussed at the generation of information 
relating to changes, at the transcriptional level, in the bovine neutrophil following incubation 
in milk pre-conditioned by the growth of S. uberis. In so doing, I aim to test the hypothesis that 
factors released during the growth of S. uberis cause changes in gene transcription that 
correlate with the loss of neutrophil function.  
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2 Methods 
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2.1 ± Preparation of Host Derived Samples 
 
2.1.1 Isolation of Bovine Blood Derived Neutrophils (PMNs) 
(See appendix for reagent preparation formulae). 
Blood was collected by jugular venopuncture into a tube containing 1.5% EDTA.  
Samples were centrifuged at 1,500 x g for 15min and the plasma, buffy coat and upper part of 
the red cell fraction removed.  The remaining fraction was weighed and transferred to a conical 
flask. 10ml of Super-Q filtered water (SQW) was added for every 2.5g of the red cell fraction 
and agitated for 30sec. A half volume of 2.7% NaCl solution was added and agitated for a 
further 10sec. The solution was centrifuged at 125 x g for 10min and the supernatant 
discarded.  The cell pellet was resuspended in PBS and centrifuged at 125 x g for 10min.  Two 
further PBS washes were performed, and after which the cell pellet was resuspended in a small 
volume of PBS. 20µl of this suspension was mixed with 20µl of Trypan blue and a 
haemocytometer used to ascertain viability of the cells by exclusion of Trypan blue and their 
concentration. Cell concentration was adjusted to 1 x 108 cells ml-1. 
 
2.1.2 Assessing Purity of the Isolated Cell Population 
The purity and viability of the PMN population isolated by the technique outlined in 2.1.1 was 
assessed on a Fluorescence Activated Cell Sorting (FACS) machine (FACSCalibur, Becton 
Dickinson), and the data analyzed using FCS Express Version3 software. 
 
Cell viability was assessed by the exclusion of propidium iodide (PI) stain using the following 
method.   Cells were suspended in PBS, centrifuged for 1min at 1200 x g, and the PBS 
removed. 25µl of 25ng ml-1of PI was added to each well, the plate mechanically shaken for 
1min, and then left for 10min.  100µl of PBS was added and the plate centrifuged again (1min, 
1,200 x g) and the PBS removed.  The cells were resuspended in 100µl PBS and added to 200 - 
500µl PBS in a FACs tube.          
 
2.1.3 Collection and Processing of Aseptic Skimmed Milk 
Using current National Milk Record (NMR) data from the Mayfield Farm Dairy unit (IAH), 
four milking heifers between 21 and 100 days-in-milk, with no recent history of high SCC or 
disease, were selected for sample collection. Teats were aseptically prepared, the foremilk 
discarded and 50ml per quarter was collected.  Samples were stored on ice during transport, 
prior to centrifugation at 2,000 x g for 10min at 4ºC, and the skimmed milk fraction transferred 
to new tubes. 500µl of milk from each quarter was plated out onto blood esculin agar, and 
incubated overnight at 37ºC to check for bacterial contamination.  The skimmed milk was 
filtered twice using 0.45µm filters (Millipore, UK).  Samples were combined, dispensed into 
aliquots and store at -20ºC.  These skimmed milk aliquots were used to culture bacteria.    
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2.2 Preparation of Bacterial Strains                                                                                                                             
 
2.2.1 Bacterial Strains  
All strains used were supplied by J.A. Leigh (Streptococcal Research Group, University of 
Nottingham) as 25% glycerol stocks, stored at -80ºC.   S. uberis 0140J and S. uberis EF20 are 
field strains isolated from cows in the 1970s; S. uberis 0145m, and 1095m are mutants 
generated by random insertional mutagenesis and sub1154m is a deletion mutant generated by 
allelic exchange mutagenesis (Leigh et al 2010).   
 
The coliform E. coli P4, originally isolated form a clinical mastitis case and proven to induce 
mastitis (Bramley, 1976),  is known to be susceptible to killing by PMNs.   It was used in the 
bactericidal assays and to assess functionality of PMNs. 
 
2.2.2 Bacterial Growth Conditions 
2.2.2.1 Todd Hewitt Broth (THB) cultures 
10ml of THB was inoculated from a stock culture of the required bacteria and left at 37ºC 
overnight.  Growth curves of the S. uberis strains and E. coli P4 in THB were determined.  
THB was inoculated and cultured overnight as above.  1.5ml of each culture was centrifuged at 
10,000 x g for 5min and pellet resuspended in 1ml of PBS.  The optical density (OD) of each 
culture was measured in a spectrophotometer (UV-160A, Shimadzu, Shimadzu-Europa, UK) at 
550nm and adjusted so that the OD of each was approximately equal to 1 at 550nm.  These 
cultures were then diluted to approximately 100cfu ml-1 in THB and the OD measured for each 
sample in triplicate using the automated Bioscreen C (Oy Growth Curves Ab Ltd, Finland), 
measuring at OD 540nm at 37°C over 16hrs. 
 
The viable population of bacteria in the THB cultures after overnight culture was confirmed, 
by serial dilution and spotting onto 1% sheep blood esculin agar.  This was replicated six 
times. 
2.2.2.2 Milk Cultures of S. uberis Strains 
1ml of S. uberis THB culture was centrifuged (2,400 x g, 2min) and the cell pellet washed in 
PBS and re-centrifuged.  10µl of a 10-2 dilution was used to inoculate 10ml of aseptically 
collected skimmed milk (see 2.1.3) and left overnight at 37ºC.  The resulting bacterial cultures 
DUHKHUHZLWKWHUPHG³PLONFXOWXUHV´   
 
The viable population of bacteria in the milk cultures after overnight culture was confirmed, by 
serial dilution and spotting onto 1% sheep blood esculin agar.  This was replicated six times. 
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2.2.2.3 RPMI Culture of 0140J 
10ml of RPMI-1640 (Sigma-Aldrich , Switzerland) in a culture flask was inoculated with 
500µl of THB culture and left overnight in a 5% CO2 incubator at 37ºC. 
 
 
2.3 Confirming the Identity of S. uberis Mutant Strains 
In order to verify the identity of each of the S. uberis mutants used in these experiments, 
genomic DNA was extracted from each using a modification of a previously described method 
(Hill and Leigh, 1989).  Polymerase chain reaction (PCR) was then performed comparing the 
PCR products obtained from the mutants to that from the field isolates, S. uberis 0140J and 
EF20. 
 
2.3.1 Extraction of Genomic DNA from S. uberis 
Genomic DNA was isolated using a modified, previously described method (Hill and Leigh, 
1989).  Briefly, bacterial cells were harvested by centrifugation (13,000 x g, 5min) from 1.5ml 
of overnight THB cultures of S. uberis strains 0140J, EF20 and vru, srtA, sub0145, sub1095 
and sub1154 mutant strains. The cell pellets was resuspended in 0.5ml of TE Buffer 
(10mMTris-Cl, 5mM EDTA, pH7.8), centrifuged (13,000 x g, 5min)  and the supernatant 
discarded.  The cell pellet was resuspended in 375µl of cell wall disruption buffer (10mM Tris-
Cl, 5mM EDTA, pH 7.8, containing 30units ml-1mutanolysin (Sigma, UK) and 10mg ml-1 
lysozyme (Sigma, UK)) and incubated at 37ºC.  After 30min, 20µl of cell lysis buffer (SDS: 
20%w/v in 50mM Tris, 20mM EDTA, pH7.8) and 3µl of proteinase K (Sigma, UK) were 
added and then the tube agitated and incubated at 37ºC for a further hour. Cell wall material 
was precipitated by the addition of 200µl of saturated salt solution and the tube vigorously 
agitated for 15sec then centrifuged (12,500 x g, 10min) to give a firm cell pellet. 
 
Avoiding transfer of the precipitated protein, 400µl of the supernatant was transferred into a 
fresh tube and an equal volume of equilibrated phenol:chloroform:isoamyl alcohol (25:24:1) 
(Sigma) was added. The tube was agitated and centrifuged (13,000 x g, 3min). Without 
disturbing any of the layer at the interface, 400µl of the upper aqueous phase was transferred to 
a fresh tube and 2volumes of ice-cold absolute ethanol was added to precipitate the DNA. 
DNA was recovered by centrifugation (13,000 x g, 5min) and air-dried for 30min before  being 
resuspended in 40µl of TE buffer (10mM Tris, 1mM EDTA, pH8.0, containing RNAaseA 
(Sigma, UK) at 20µg ml-1), incubated at 4ºC for 30min then further incubated at 37ºC for 
20min.  
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2.3.2 Polymerase chain reaction (PCR) of Bacterial DNA 
PCR amplification was carried out using gene primers that spanned sections of the coding 
sequence of interest. All reactions were carried out in 25µl aliquots as described below. 
Genomic DNA was diluted 1/10 in molecular grade water (Sigma, UK) with 1µl used in each 
reaction along with, 5µl 5×High Fidelity (HF) PCR buffer (New England Biolabs, UK), 2.5µl 
2mM dNTP stock, 1.25µl 10mM forward primer, 1.25µl 10mM reverse primer and 13.5µl 
water. Reactions were placed on ice and 0.5µl Phusion polymerase (New England BioLabs, 
UK) added. The primers and amplification programs used are shown below in Table 2.1.  5µl 
of amplified DNA analysed by gel electrophoreses using a 0.8% agarose/TAE buffer gel, with 
+\SHUODGGHU%LROLQH8.ZDVXVHGDVDPDUNHUWRGHWHUPLQHWKH PCR product size. 
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 Table 2.1 Primers and Amplification Programs used for PCR of bacterial Genomic DNA 
 
Mutant of Interest Primers Primer Sequence Amplification Program
sub0145 Sense 
P635
262 bp upstream from sub0145 start codon   5'-
7*$7*7*$7$***7$&77&$$&777&ƍ
sub0145 Antisense 
P636
 1913 bp from sub0145 start codon, 365 
downstream of stop codon  5'-
7*$7$7*$&&*$7*$*$7**$&ƍ
sub1095 Sense 
P645
 370 bp upstream of sub1095 start codon, 5'-
$7&$$$&7$77*7$&&&777**7*$ƍ
sub1095 Antisense 
P646
1480 bp downstream of sub1095 start codon, 25bp 
downstream of stop codon,  5'-
7*7$$7*$$7&7$**$****7$**7ƍ
sub1154 - deletion mutant Sense 
P615
 162 bp upstream of sub1154 start codon,  5'-
GAAATGATGATGAGAAATTGAGA-3'
sub1154 - deletion mutant Antisense 
P410
ESIURPVWDUWFRGRQ¶
ATGTCAAAAGCCCGGTACCTTTACAG-3'
SrtA (sub0881) Sense 
P625
135 bp upstream from sub0881 start codon 5'-
TGGAATTCTAATAGATACCAAGTGC-3'
SrtA (sub0881)
Antisense 
P626 5'-CATTTAATTTCATATGGTACCCCTTAAA-3' 
vru (sub0144) Sense 
P405
ESGRZQVWUHDPIURPYUXVWDUWFRGRQ¶
CATCGAAGGGGGTCTCATTTA-3'
vru (sub0144) Antisense 
P406
ESXSVWUHDPIURPYUXVWDUWFRGRQ¶
TTGAGAAAGCTGTCCCTGCT-3'
98°C 30sec x1
98°C 10sec, 58°C 20 sec, 72°C 30sec x35
72°C 2min30sec x1
98°C 30sec x1
98°C 10sec, 58°C 20 sec, 72°C 40sec x35
72°C 2min30sec x1
98°C 30sec x1
98°C 10sec, 58°C 20 sec, 72°C 1min15sec x35
72°C 2min30sec x1
As sub0145
98°C 30sec x1
98°C 10sec, 58°C 20 sec, 72°C 45 sec x35
72°C 2min30sec x1
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2.4  Experimental Protocols to Investigate the Interactions of PMNs with S. uberis in 
Milk 
 
2.4.1 Assessing the Susceptibility of S. uberis -¶V WR WKH %actericidal Action of 
PMNs. 
1 x107 of blood isolated PMNs were added to 3ml of 0140J milk culture, and placed on a 
Coulter Roller (Stuart, SRT9) at 37ºC.   100µl samples were taken at 0, 15, 30 60 and 120min.  
Serial dilutions performed for each time point, plated out onto blood esculin agar and incubated 
overnight at 37ºC.   This was repeated using PMNs from 6 healthy animals. 
 
2.4.2 RNA Processing to Assess the Effect of Exposure to S. uberis 0140J on PMN 
Transcription 
At the time points listed in 2.4.1, 500µl samples were taken and centrifuged at 6,200 x g for 
3min.  The supernatant was discarded and the cell pellet resuspended in 1.5ml of Tris-EDTA 
buffer (Fluka® Analytical, Sigma Aldrich,UK). Samples were re-centrifuged and the pellet 
UHVXVSHQGHG LQORI5/7EXIIHUZLWKORIȕ-mercaptoethanol added per 1ml of RLT.  
The RNA was extracted using the RNeasy® Mini Kit (Qiagen, UK) and contaminating DNA 
removed (DNA-free, Ambion, UK). 
 
2.4.3 Determining PMNs Ability to Kill Susceptible Bacteria 
E coli P4 is known to be susceptible to the bactericidal actions of healthy PMNs.  To confirm 
that the isolated PMNs from each animal were functional, a 3ml aliquot of milk, of the same 
stock as used to culture strains of S. uberis (as detailed in 2.4.1) was inoculated with 104 E. coli 
in 100µl of PBS.  1 x107 of blood-derived PMNs was then added, and placed on a Coulter 
Roller at 37ºC.   100µl samples were taken at 0, 15, 30 60 and 120min.  Serial dilutions 
performed for each time point, plated out onto blood esculin agar and incubated overnight at 
37ºC.   . 
 
2.4.4 Determining the Susceptibility of S. uberis EF20 and 0145m, 1095m, and 1154m 
to the Bactericidal Activity of PMNs 
The procedures outlined in 2.4.1 was repeated using milk cultures of S. uberis strains EF20, 
0145m, 1095m and 1154m. 
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2.5 Experimental Protocols to Investigate the Interactions of PMNs with the 
Supernatants from Cultures of S. uberis 0140J 
The inhibitory effect of S. uberis 0140J on bovine PMNs also occurs if the cells are exposed to 
the supernatant of S. uberis 0140J milk cultures (Field et al., 1997), indicating that the effector 
molecule mediating the inhibition is released from the bacteria into the surrounding milieu and 
does not require the continued presence of the bacteria themselves. 
 
2.5.1 Generating S. uberis Culture Supernatants 
S. uberis milk cultures were prepared as described in 2.2.2.2.  The milk was then passed twice 
through a 0.45µm filter (Millipore, UK) in aseptic conditions to remove the bacteria.  A sample 
of the culture was serially diluted for assessment of bacterial load pre-filtering, and a post-
filtering 500µl sample plated out onto blood esculin agar to confirm that the supernatant 
contained no bacteria.  Supernatants were either used fresh or stored as aliquots (3ml) at -80ºC, 
until required. Aliquots of the same milk used to culture S. uberis were stored under identical 
conditions to ensure the equivalent control was used throughout further experiments. 
 
S. uberis RPMI cultures were prepared as described in 2.2.2.3.  RPMI supernatants were 
generated and stored as detailed above for the milk supernatants. 
 
2.5.2 Assessing the Effect of Fresh and Frozen 0140J Culture Supernatants on the 
Bactericidal Activity of PMNs 
The ability of 0140J culture supernatants to inhibit the bactericidal function of PMNs was 
assessed. In addition, the effect of freezing the supernatant was investigated.  Freshly prepared 
supernatant was aliquoted into 900µl vials, and half of the samples frozen at -80ºC; and 
subsequently thawed at room temperature 30min later. Once all samples were at room 
temperature, 100µl of a 1 x 108 cells ml-1 PMN suspension was added to vials containing 900µl 
of milk, fresh milk supernatant (MS) or frozen milk supernatant (FMS) that had been thawed. 
 
Samples were then placed on a Coulter Roller at 37ºC and incubated for 2hr.  From each 
sample a 200µl aliquot was taken and used in a bactericidal assay.  This was added to a vial 
containing 100µl 30%v/v complement-deactivated serum, as a source of opsonin, and 90µl of 
PBS.  Finally, 30µl of 106ml-1 E. coli P4 culture was added and the vials placed on a Coulter 
Roller at 37ºC for 90min. Bacterial serial dilution counts were performed using 100µl samples 
taken at 0 and 90min.  
 
This was replicated using PMNs isolated from 6 different animals.  The reduction in the E.coli 
populations in the presence of the differently treated PMNs was analysed by a one-way 
ANOVA with Tukey post test, using GraphPad Prism 4 software. 
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In parallel, the experiment was performed using RPMI, fresh RPMI supernatant and frozen 
RPMI supernatant. 
 
2.5.3 Processing PMN-derived RNA 
The remaining fraction containing 8x106 PMNs from the incubation stage of 2.5.2 was 
collected in microfuge tubes and centrifuged at 6,200 x g for 1min at room temperature.  The 
supernatant was removed and stored at -20ºC for further analysis (2.5.8).  The cell pellet was 
resuspended in 1.5ml of TE buffer (10mM-Tris-HCl-1 EDTA pH 7.6), centrifuged at 6,200 x g 
for 1min and the supernatant discarded. Cells were then lysed by resuspending the pellet in 
OEXIIHU5/74LDJHQ51HDV\NLWZLWKORIȕ-mercaptoethanol added per every 1ml of 
buffer RLT.  The RNA was isolated using the RNeasy® Mini Kit (Qiagen) and contaminating 
DNA removed (DNA-free, Ambion, UK). 
 
2.5.4 Amplification of RNA for Microarray Analysis  
8VLQJ WKH $PLQR $OO\O 0HVVDJH$PS ,,-96 Kit (Ambion®), 200ng of the RNA was 
DPSOLILHG DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV, and including the optional second 
round amplification steps.  The amplified RNA, 2.5µg of each sample, was labelled separately 
with Alexa Fluor® 555 or Alexa Fluor® 647 fluorescent probes.  For each animal the labelled 
RNA from milk-treated PMNs was combined with oppositely labelled RNA from 0140J milk 
culture supernatant-treated PMNs.  Samples were fragmented (RNA Fragmentation Reagents, 
Ambion, Texas, USA) and diluted in hybridization solution (SlideHyb Glass Array 
Hybridization Survey Kit and buffers, Ambion, Texas, USA). 
 
2.5.5 RNA Hybridization for Microarray Analysis 
BloPlus (Bovine Long Oligo Plus Microarray) (CAFG, Michigan State University, USA) 
contains approximately 8400 70mer oligos printed in duplicate, with numerous positive and 
negative control spots. 
 
Pre-processing, hybridisation and washing of micURDUUD\VZHUHSHUIRUPHGLQD7HFDQ+6
Pro Hybridization Station (Tecan UK Ltd, Reading, UK).  Slides were pre-processed at 23°C 
with sodium dodecyl sulfate (SDS) 1% (SDS 10%, Gibco ultrapure, Invitrogen) for 2min, then 
with deionised water for 2min and dried at 30°C for 2min.  The hybridization programme 
commenced with a wash step for the slides with medium stringency buffer at 45°C for 1min.  
Samples were then injected and automatically agitated.  Hybridization at 45°C, with medium 
agitation and under high viscosity conditions was performed for 6hr.  The hybridization step 
was repeated at 40°C then at 35°C.  Slides were then washed  with medium stringency buffer 
for a rinse step of 20sec and a soak time of 30sec for 5 cycles at 45°C, then with high 
stringency buffer  for 5 cycles at 40°C, followed by 5 cycles at 40°C with the post wash buffer.  
Microarrays were dried for 2min at 30°C with nitrogen. See Appendix 1 for buffer recipes.  
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2.5.6 Microarray Analysis 
The hybridised slides were scanned using an Axon GenePix 4000A microarray scanner 
(Molecular Devices Ltd., Wokingham, UK).  Spots were manually checked using Axon 
GenePix Pro 6.0 software (Molecular Devices Ltd.).  Limma  (Smyth, 2004) within the R-
project statistical package (Copyright, R-Foundation) was used to statistically analyse the data.  
All slides were normalized by Print-Tip Loess Normalization. Basic Local Alignment Search 
Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis of all differentially expressed 
genes with a p-value of < 0.05 was performed in order to identify the genes of interest.  Data 
were analyzed through the use of Ingenuity Pathways Analysis (IPA) (Ingenuity® Systems, 
www.ingenuity.com). 
 
As information regarding bovine genes is limited compared to human genes, human 
homologues to identified bovine genes were used as the input data set where possible.  
Pathways in the results section were generated by cross-referencing between IPA pathways and 
KEGG pathways (Kyoto Encyclopaedia of Genes and Genomes: www.genome.jp/kegg/). 
 
 
2.5.7 Quantifying the Proportion of Apoptotic Cells in Isolated Cell Populations after 
Incubation in Milk or S. uberis 0140J Milk Supernatant 
PMNs were incubated for 2hr in aliquots of milk and frozen S. uberis 0140J milk supernatant 
(see section 2.4.1),following the method outlined in 2.4.2, The cell pellet was isolated by 
centrifugation (4,000 x g, 2min) and washed twice in PBS.  To block the Fc Receptor binding 
Annexin V, 1 x106 cells of each sample were resuspended in 100µl of mouse serum (Sigma) 
for 10min, centrifuged (1,000 x g, 2min) and the serum discarded. Cells were then stained with 
the ApoVFUHHQ$QQH[LQ9$SRSWRVLV.LW6RXWKHUQ%LRWHFK86$IROORZLQJPDQXIDFWXUHU¶V
protocol, and analysed by FACs. 
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2.5.8 Real Time Quantitative Polymerase Chain Reaction  
Quantitative polymerase chain reaction (q-PCR) was used to assess levels of transcript in PMNs 
that had been exposed to milk or the supernatant of S. uberis 0140J milk culture as a means to 
indentify relevant time points from which microarray studies could be performed. In addition, q-
PCR was used to validate up/down regulated genes identified from microarray studies. 
2.5.8.1 Generation of PMN cDNA 
In each case 100ng RNA was reverse transcribed using SuperScript® III First-Strand Synthesis 
System for RT-PCR (Invitrogen, UK) DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV. This was used 
as template for subsequent Q-PCR reactions. 
2.5.8.2 qPCR Probes and Primers 
Primers and probes for GAPDH (Glyceraldehyde 3-phosphate dehydrogenase.) (Collins et al., 
1999), CXCL8 (Widdison et al., 2008), IL-6, IL-10 and IL-12p40 (Werling et al., 2002) have 
been previously reported. Additional primers and probes (Table 2.2), identified from microarray 
studies and similar projects carried out within the Bovine Genomics group, were designed using 
GenScript Real-time PCR (TaqMan) Primer Design tool (available at www.genscript.com). 
Where available primers and probes were chosen to cross intron:exon boundaries. 
2.5.8.3 qPCR Protocol 
Complementary DNA (100ng) was used as the starting material for qPCR with samples being 
assayed in triplicate.  Primers and probes were mixed with the appropriate volume of TaqMan 
FAST Universal PCR Mastermix (Applied Biosystems, Warrington, UK) and applied to the wells 
before initiating the ABI Prism 7500 Fast Real-Time PCR System (Applied Biosystems).  The 
amplification program used applied and initial denaturation step at 95°C for 20 seconds followed 
by 40 cycles at 95°C for 3 seconds and 60°C for 30 seconds. All results were quantified against 
plasmid standard curves. For each target gene, mRNA levels were normalised to the 
housekeeping genes (HK) according to the formula (Copy No. Target/Copy No.HK).  
Constitutive expression RI*$3'+ȕ-actin and boRPL2 was assessed to validate their potential 
use as HK genes. 
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Table 2.2 qPCR Primer and Probe Sequences  
 
 
 
 
 
 
 
 
 
  
ID   Forward Primer (5'-3') Reverse Primer (5'-3') Probe (5'FAM-3'TAMRA) 
ȕ-actin GAGGCTCTCTTCCAGCCT GAAGGTAGTTTCGTGAATGCC TTCCTGGGCATGGAAT  
 
RPLP0 
 
GCACAATTGAAATCCTGAGTG 
 
GGGTTGTAGATGCTGCCATT 
 
AGCGAAGCCACGCTGCTGAA  
 
RPLP2 
 
TCAACAAGGTCATCAGTGAGC 
 
CCGATACCCTGAGCAATGA 
 
CGTCCTCGATGTTCTT  
 
CCL20 
 
TCAGAAGCAAGCACTTCGAC 
 
GATGTCACAGGCTTCATTGG 
 
CCAGCTGCTGTGTGAAGCCCA  
COX-2 CTAACGACAAAGCTGACCCA GAATTCGTAAAGAAGGAAGAGCA CTGAACCATTCTGCCCGCCA  
NFKB1A TGCACTTAGCCATCATCCAT GCGATTTCTGGCTGGTTAGT CCTGCAGCAGACGCCACTCC  
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2.5.9 &;&/DQG,/ȕEnzyme-Linked ImmunoSorbent Assay  
Enzyme Linked ImmunoSorbent Assays (ELISAs) for CXCL- DQG ,/ȕ (/,6$V ZHUH
performed on the supernatants of MT and ST PMNs (see 2.5.3) to reveal whether up-
UHJXODWLRQ RI &;&/ DQG ,/ȕ DW WKH WUDQVFULSW OHYHO HTXDWHV WR DQ LQFUHDVH Ln protein 
production.  
 
Capture mAb, MAB208 (R&D Systems, UK) and CC301 (IAH,UK), were diluted in 50mM 
carbonate/bicarbonate buffer pH 9.5, applied to the wells of 96-well Maxisorp plates (Thermo 
Scientific, UK) and incubated overnight at room temperature (RT).  Following five washes 
with PBS Tween20 (0.05% v/v), plates were blocked by the addition of 300 l/well of blocking 
buffer (1mg/ml casein in PBS) and the plate incubated at RT for 1hr.  After washing, 90µl/well 
of supernatant from the MT and ST incubations was added to wells, in duplicate, as well as 
90µl of standards (100 ngml-1, four further 1:3 dilutions in blocking buffer and a negative 
control).  
 
6DPSOHV ZHUH LQFXEDWHG DW 57 IRU KU ZDVKHG DQG ȝO ZHOO RI ELRWLQ\ODWHG GHWHFWLRQ
antibody diluted in blocking buffer applied to each well (IL-8; BAF-208, IL-12; CC326B).  
Samples were incubated at RT for 1hr and the plate washed as previously described.  
Biotinylated mAb was detected by the application of 100µl/well Streptavidin-HRP solution 
(Amersham-Pharmacia, UK) (in PBS, Tween 20 0.05% v/v). Following a final incubation of 
45 min and subsequent washing, bound streptavidin-HRP was detected using Super Signal® 
ELISA Femto Solution (Thermo Scientific, UK) and the plate was read immediately using a 
flurometer (FLUOstar Optima, BMG Labtech, UK). Following construction of a standard 
curve, concentrations of chemokines in supernatants was evaluated. 
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3 Results  
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3.1 PMN Population Purity 
 
The hypotheses this project tests are based on data derived from experiments in which PMNs 
have been isolated as described in section 2.1.1..  The population of cells isolated from four 
animals that also provided the cells for RNA extraction and functional assays were assessed 
for composition and viability by Fluorescence Activated Cell Sorting (FACS) analysis.  Of the 
cells in the population, 94.8% (SD 0.83) were PMNs; of this population 99.3% of the cells 
were propidium iodide ±ve (P.I.-ve)(n=4; SD=0.74).  Hereafter, the isolated population will be 
known as PMNs throughout this work. 
 
 
Fig 3.1 FACs Plot of Cell Population Isolated from Whole Blood 
 
Using the Methods described in section 2.1.1 a blood-derived PMN were isolated from 4 animals.  FACs 
analysis revealed a purity of 94.8% (SD 0.83). Within the PMN population (blue arrow and outline) 
96.7% (SD 0.43) were within one subset (red outlined area). Small populations (1.8% (SD 0.15) and 
1.5% (SD 0.43)) appeared either, slightly larger and more granular - higher side scatter levels (y axis) or 
larger - higher forward scatter levels (x axis). 
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3.2 Bacterial Growth 
To adequately compare different strains of S. uberis 0140J it is essential to know if they 
behave similarly in growth media, and attain similar population levels in the stationary phase. 
 
3.2.1 Growth of Different Strains of S. uberis and E. coli P4 in THB  
Growth of the different bacterial strains over 16hrs in THB was assessed using the Bioscreen C 
automated system.   S. uberis strains grew to a similar optical density, although strain EF20, 
and the mutants Vru and SrtA grew to slightly higher optical densities than the wild type 0140J 
and the sub0145, sub1095 and sub1154 mutants.  S. uberis strains 0140J, EF20, and the mutant 
Vru attained viable counts of approximately 5 x 107 cfu ml-1 after overnight incubation of THB 
cultures at 37°C in glass universal vials.  Mutant strains SrtA , sub0145 and sub1095 grew to a 
slightly lower level with the latter only attaining 6 x 106 cfu ml-1.  The mutant sub1154 
appeared to grow slightly better than the others tested reaching 8 x 107 cfu ml-1. The Bioscreen 
revealed that the mutant with a lesion in sub1095 showed a greater lag and grew at a slightly 
slower rate than the other strains. E.coli P4 grew to a higher magnitude, to a viable count of 
approximately 1 x 109 cfu ml-1. (Fig 3.2 (a) and (b)). 
 
3.2.2 Growth of S. uberis Strains in Overnight Milk Cultures  
As described in section 2.2.2.2 S. uberis strains were cultured in milk.   S. uberis strains 0140J, 
EF20 and mutants Vru and SrtA attained viable counts of 1x108 cfu ml-1 after overnight 
incubation in milk at 37°C in glass universal vials.  Mutant strains sub0145, sub1095 and 
sub1154 reached 1 -3 x 107 cfu ml-1. (Fig 3.3). 
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Fig 3.2 Growth Curve of Different Strains of S. uberis and E. coli P4 in THB 
 
Growth of strains of S. uberis and E. coli P4 in THB at 37ºC was assessed in triplicate by both (a) optical 
density; a 16hr growth curve determined using the automated Bioscreen C and (b) viability; counts 
performed by serial dilution and spotting onto 1% sheep blood esculin agar plates after growth in glass 
vials overnight. Plots show mean values, error bars represent standard deviation (SD). 
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Fig 3.3 Growth of S. uberis Strains in Overnight Milk Cultures 
Growth of strains of S. uberis and E. coli P4 in milk at 37ºC was assessed by viability counts performed 
by serial dilution and spotting onto 1% sheep blood esculin agar plates after inoculation of 10ml of milk 
with approx 104 bacteria in triplicate and incubation in glass vials overnight. One-way ANOVA revealed 
no significant differencs between growth rates of strains.  Plot shows mean values, error bars represent 
SD. 
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3.2.3 Confirmation of the identity of Mutants of S. uberis 0140J by PCR Amplification 
To confirm to identity of the mutant strains, genomic DNA was isolated and polymerase chain 
reaction (PCR) carried out (See Fig 3.4). 
 
The mutant strains of Vru (lane A,3),SrtA (lane B,3 ± not easily visibly), sub0145 (lane C,3) 
and sub1095 (lane D,3) each have an 800bp insertion within the gene of interest compared to 
wild type 0140J (lanes 1), confirming disruption of the gene via plasmid insertion (Vru (Ward 
et al., 2003); SrtA, sub0145, sub1095 (Leigh et al., 2010)). The mutation in the sub1154 gene 
(lane E,3) was produced by allelic exchange, removing 3700bp of the gene (Leigh et al., 2010).  
This is confirmed by the production of an amplicon of approximately 500bp.  
 
Comparison of the avirulent wild type S. uberis EF20 (lanes 2) to the virulent 0140J, shows 
gene products of identical size for the vru (A) and sub1154 genes (E). The gene products of S. 
uberis EF20 for Sub0145(C), sub1095 (D) are slightly larger compared to 0140J. The genome 
sequence of S. uberis EF20 to date is unpublished and small differences in PCR product sizes 
most likely reflect coding but not necessarily functional differences in these genes (P.N. Ward, 
unpublished data). For SrtA (B,2) no band is seen for S. uberis EF20.  This may reflect the 
mismatch of 5 bp compared to the antisense primer, which under these annealing conditions, 
could be sufficient to prevent amplification of the DNA (P.N. Ward, unpublished data). 
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Fig 3.4 Confirmation of Individual S.uberis 0140J Mutants by Polymerase Chain 
Reaction. 
 
PCR products from primer sequences for the following genes are shown with S. uberis 0140J and S. 
uberis EF20 strain products in lanes 1 and 2 respectively and the product form each individual mutant in 
lane 3. Amplification of specific genes was as follows; A: vru, B: SrtA, C: sub1045 D: sub1095 and E: 
sub1154. Lane M indicates the DNA marker Hyperladder, with all sizes represented in base pairs (bp).   
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3.3 Interaction of PMNs with Different Strains of S. uberis in Milk 
Culture 
To explore the development of an in vitro model to investigate the early interactions between 
PMN and pathogen different strains of S. uberis were cultured in milk overnight and blood-
derived PMNs added. 
 
3.3.1 Evaluation of the Susceptibility of Different Strains of S. uberis to the 
Bactericidal Actions of PMNs 
 
The field isolated S. uberis EF20 and the mutants Vru, SrtA, sub0145, sub1095 and sub1154 
all show reduced virulence in the host compared to S. uberis 0140J.  To ascertain if this 
attenuation is due to susceptibility to the bactericidal actions of PMNs, blood-derived PMNs 
were added to milk cultures of S. uberis strains.  Bacterial counts were performed over 2hrs 
(Fig 3.5 (a)). SrtA was not tested.  In parallel, an aliquot of the same skimmed-milk was 
inoculated with E. coli P4 to achieve an equivalent population as for S. uberis cultures, PMNs 
were then added. No significant changes in the populations of the different strains of S. uberis 
were seen. The E. coli P4 population was reduced to less than 1% of the original level (Fig 3.5 
(b); a level significantly different from the populations of S. uberis 0140J, EF20, Vru, and sub 
1154 (p<0.01**). 
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Fig 3.5 (a) Bacterial Counts of Milk Cultures, in the Presence of PMNs 
 
PMNs were added to overnight milk cultures of different S. uberis strains and milk into which an 
equivalent number of E. coli P4 had been added.  Bacterial viability counts performed by serial dilution 
and spotting 1% sheep blood esculin agar plates were carried out at 0, 30, 60 and 120min. 
n=6, graph show mean values, error bars represent SD 
 
 
Fig 3.5 (b) Log10 Survival of Bacterial Strains in Milk in the Presence of PMNs 
 
One-way ANOVA analysis of bacterial survival over the 120min incubation period with PMN, revealed 
E.coli P4 population was significantly different p<0.01 to those of S. uberis strains 0140J, EF20, Vru, 
sub1154.  S. uberis population were not significantly changed by the presence of PMNs. 
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3.4 The Effect of Supernatants from Cultures of S. uberis 0140J on 
PMNs 
To investigate the effects of the soluble factors released by S. uberis on PMN function 
experiments exposing PMNs to the supernatants of bacterial cultures were performed.  This 
enables the distinction of effects mediated by the products of S. uberis rather than its presence. 
 
3.4.1 Inhibition of the Bactericidal Activity of PMNs by Incubation in the Supernatant 
of S. uberis 0140J Milk Cultures.  Freezing at -80°C does not Negate its 
Inhibitory Effects 
To standardise experimental conditions over time, the use of the same bacterial-derived 
inhibitory media on different days would be advantageous.  Capsular extract from S. uberis 
cultures has previously been shown to inhibit PMNs phagocytic actions.  To corroborate these 
findings and investigate if storing the culture supernatants at -80°C affects their inhibitory 
effect, PMNs were incubated for 2hr in milk ³PLONWUHDWHG´07, fresh S. uberis 0140J milk 
culture supernatant ³VXSHUQDWDQWWUHDWHG´67and S. uberis 0140J milk culture supernatant 
that had been frozen at -80°C and thawed before use ³)UR]HQ VXSHUQDWDQW WUHDWHG´ )67.  
The PMNs were then isolated and their effect over 2hr on a population of E. coli P4 measured 
(Fig 3.6).  MT PMNs reduced the E. coli P4 population by 3.5 log10.  This reduction was 
significantly (p<0.01**) greater than that detected in ST and FST PMNs. Freezing the milk 
supernatant prior to use had no effect on its inhibitory activity towards bovine PMN. 
 
3.4.2 Bactericidal Activity of PMNs is not Significantly Affected by Incubation in the 
Supernatant of S. uberis 0140J Grown in RPMI  
 
It is not known whether S. uberis 0140J cultured in media other than milk produces the soluble 
factor(s) that cause the inhibition of the PMNs bactericidal actions. Milk-derived media will 
inherently vary in composition continuously.  A more robust model using a standardised, 
commercially available media would be preferential; RPMI is widely used worldwide to 
culture mammalian cells including PMNs.  Although PMNs incubated in RPMI showed 
greater bactericidal action than PMNs incubated in either the fresh or frozen S. uberis 0140J 
RPMI culture supernatant, this difference was not significant (Fig 3.7).   
 
 
 
 
 
 
 
 
 
 
 
 
 43 
 
 
Fig 3.6 E. coli P4 survival in the presence of PMNs incubated in milk & in S. uberis 0140J 
milk culture supernatant 
 
 
The ability of PMNs to kill E. coli P4 after incubation for 2hr in milk (MT), supernatant from S. uberis 
0140J milk culture (ST) and supernatant from S. uberis 0140J milk culture that had been stored at -80ºC 
then thawed (FST) was assessed.  Box and whisker plots are shown, box represents interquartile range; 
error bars indicate maximum and minimum values.  n=6.  The E. coli population in the presence of MT 
PMNs was reduced significantly different level compared to E. coli P4 in the presence of ST and FST 
PMNs.  There was no statistical difference between the reduction of the E. coli populations in the 
presence of ST and FST PMNs. 
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Fig 3.7 E.coli P4 Survival in the Presence of PMNs Incubated in RPMI or S. uberis 0140J 
RPMI Culture Supernatant 
 
 
The ability of PMNs to kill E. coli P4 after incubation for 2hr in RPMI, supernatant from S. uberis 0140J 
RPMI culture and supernatant from S. uberis 0140J RPMI culture that had been stored at -80ºC then 
thawed was assessed.  Box and whisker plots, box represents interquartile range; error bars indicate 
maximum and minimum values.  n=6.  No statistical differences in the reduction of the E. coli 
populations were seen. 
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3.4.3 Differences in the Transcriptome of PMNs Incubated in S. uberis 0140J Milk 
Culture Supernatant from that of PMNs Incubated in Milk and the Functions of 
the Differentially Expressed Genes 
 
RNA from MT and ST PMNs was amplified and used to perform a dye-swap microarray 
experiment. The data was captured using an Axon GenePix Scanner with Gene Pix Pro 6.0. 
 
The results were then analyzed using R which identified that of the 8400 genes represented on 
the BloPlus Microarray, 328 were differentially expressed in the ST PMNs compared to MT 
PMNs, having a p-value of < 0.05.   These were termed the differentially expressed genes 
(DEG). For each DEG the human homologues was identified and the online IPA Ingenuity 
software used to identify associations between them.  When the adjusted p-values were 
calculated (0.99 for all DEG) these indicated that with the present data set no results can be 
classed as statistically significant.   
 
Tables 3.2 and 3.3 shows the top DEGs in ST PMNs relative to the expression levels in MT 
PMNs. Table 3.2 shows the top 15 up-regulated DEGs and Table 3.3 the top 15 down-
regulated DEGs.  Of these up-regulated genes, 14 are known to be involved in inflammatory 
pathways or intracellular function, the function of the remaining one is unknown.  Of the 
down-regulated genes, three are known to occur in apoptotic pathways, while others relate to 
cell membrane and cytoplasmic structure and sequestration of metal ions. 
 
IPA Networks are molecular maps representing proven molecular relationships allowing in 
silico combination of established pathways.  IPA identified networks in which the DEG are 
represented, this is a basis of directing further analysis at the metabolic area of relevance; 
Associated Network Functions (Table 3.4 (a)), Diseases and Disorders (Table 3.4(b)) and 
Molecular and Cellular Functions (Table 3.4(c)).  Although more applicable to a whole tissue 
model, this data is a useful way of analysing the results obtained, and has given an indication 
of the networks and pathways affected in the ST PMNs. 
 
Inflammatory and apoptotic pathways were identified by the IPA analysis as key areas of 
interest. Using the software, lists of DEGs associated with these pathways were generated 
(Tables 3.5 and 3.6.) and a speculative pathway designed.  These are represented graphically in 
Fig 3.8 and 3.9.  
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Table 3.2  Top 15 Differentially Up-regulated Genes in PMNs Incubated in S. uberis 0140J Supernatant 
Compared to PMNs Incubated in Milk and their known Functions. 
 
Fold Change and Log Ratio shown. 
 Molecule Log Ratio Fold Change Also Known As Function
SUPT3H 2.05 4.15 Suppressor of Ty 3 homolog/ SPT3 homolog Predicted: Transcription initiation protein 
PYROXD2 1.80 3.47
Pyridine nucleotide-disulphide oxidoreductase 
domain 2
A FAD-dependent pyridine nucleotide-disulphide oxidoreductase, 
most likely involved in Respiratory Burst Pathways
PTGS2 1.73 3.31 COX-2
Inducible catalyst of the rate-limiting step of prostaglandin 
production. Major mediator of inflammation 
ATP2B1 1.60 3.03 plasma membrane Ca ATPase Critical role in intracellular calcium homeostasis, Mg dependent
IL12B 1.57 2.96 NK cell stimulatory factor chain 22 Notably expressed by activated macrophages/monocytes, Tcells 
and mast cells.  Broad biological activities
SLC7A5 1.39 2.62 MPE16/LAT1 Involved in cellular amino acid uptake
BAT2 1.33 2.51 HLA-B associated transcript 2 Gene co-localised with TNF alpha and TNF beta genes. In the human, all within the MHC class III region.
CCL20 1.30 2.46 MIP3A Chemotactic factor that attracts lymphocytes and, slightly, 
neutrophils, but not monocytes
CPT1A 1.28 2.42  - Key enzyme in mitochondrial oxidation of long-chain fatty acids
SPIB 1.23 2.34  - 
PU-box  specific transcriptional activator, expressed in 
hematopoietic cells including neutrophils
IL8 1.16 2.23 CXCL8 Released in response to inflammatory stimulus. Chemotactic for 
neutrophils, basophils and T-cells.  Involved in neutrophil activation
MAPKAPK2 1.15 2.22 MK2 Regulated by p38 MAP kinase. Involved in stress and inflammatory 
responses, nuclear export, and gene expression regulation 
STARD7 1.13
2.19 StAR-related lipid transfer (START) domain 
containing 7
Unknown function.  Gene contains a region similar to the START 
domain, which is often present in proteins involved in the cell 
signaling mediated by lipid binding
MKNK1
1.12
2.17
MAP kinase interacting serine/threonine kinase 
1
Appears to regulate transcriptionand play a role in the response to 
environmental stress and cytokines
BCL2A1 1.11 2.15 BCL2-related protein A1
Its encoded protein decreases caspase activation and CytochromeC 
release (pro-apoptotic) from mitochondria . Its transcript, via NF-
kappa B, is up-regulated by several extracellular signals, including 
GM-CSFand inflammatory cytokines TNF and IL-1.
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 Molecule Log Ratio Fold Change Also Known As Function
DFF40 -1.14 2.20 CAD/DFFB
DFFA is the substrate for caspase-3 and triggers DNA 
fragmentation during apoptosis
RNF145 -1.10 2.15 ring finger protein 145 Unknown
MAPK9 -1.10 2.14 JNK2/SAPK
Targets specific transcription factors,. Mediates 
immediate-early gene expression in response to various 
cell stimuli
GUSB -1.09 2.13 beta-glucuronidase2 Hydrolase that degrades glycosaminoglycans
MICAL1 -1.07 2.10 NICAL
A microtubule associated monoxygenase thought to be a 
cytoplasmic scaffolding protein
CYB561D1 -1.04 2.06 Cytochrome b-561 domain 
containing 1 
Secretory vesicle-specific electron transport protein. It is 
an integral membrane protein.
AGPAT3 -1.04 2.06 1-AGP acyltransferase3 May be an integral membrane protein. Key enzyme in de 
novo phospholipid biosynthetic pathway
DCUN1D5 -1.03 2.03 DCN1 scaffold-like E3 ligase for cullin neddylation 
FOS -1.00 2.00
FBJ murine osteosarcoma viral 
oncogene/AP-1
Forms the transcription factor AP-1 (with JUN) . 
Implicated as regulator of cell proliferation and and also in 
apoptotic cell death
UCP2 -1.00 1.99 uncoupling protein 2
Mitochondrial uncoupling protein, separates oxidative 
phosphorylation from ATP synthesis with energy 
dissipated as heat
SLC39A1 -0.99 1.99 ZIP1
Mediates zinc uptake. May function as a major 
endogenous zinc uptake transporter in many cells of the 
body
Unknown -0.99 1.99 ? ?
FGL2 -0.98 1.97 fibrinogen-like 2 /T49 Serine protease activity.  Immune coagulant
LTB -0.95 1.94 lymphotoxin beta / Tumor 
necrosis factor C
Member of the TNF superfamily. Forms part of the 
primary ligand for the lymphotoxin-beta receptor.  An 
inducer of the inflammatory response system.
SLC40A1 -0.93 1.91
Solute carrier family 40 (iron-
regulated transporter), member 
1-like
Identified in Macrophages and endothelial cells. 
Important in iron-sequestering
Table 3.3  Top 15 Differentially Down-regulated Genes in PMNs Incubated in S. uberis 0140J Supernatant 
Compared to PMNs Incubated in Milk and their known Functions 
 
Fold Change and Log Ratio shown. 
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Table 3.4 (a) IPA Analysis, List of Top Networks 
Tables show the Top Bio Functions identified by IPA, including both direct and indirect relationships 
between DEG.  p-values shown reflect the range of significance of the differential expressed genes within 
the identified pathway/function 
 
 
 
Table3.4 (b) IPA Analysis, List of Top Diseases and Disorders 
 
 
 
 
Table3.4 (c) IPA Analysis, List of Top Molecular and Cellular Functions 
 
 
 
  
Diseases and Disorders p-value # Molecules
Dermatological Diseases and Conditions 1.21E-07 - 1.73E-03 35
Cancer 4.10E-07 - 2.34E-03 88
Organismal Injury and Abnormalities 7.67E-07 - 2.47E-03 24
Infection Mechanism 1.64E-06 - 2.27E-03 19
Inflammatory Disease  1.72E-06 - 2.06E-03 74
Molecular and Cellular Functions p-value # Molecules
Cell Death 5.84E-10 - 2.38E-03 77
Cellular Movement 9.97E-08 - 2.50E-03 56
Cellular Growth and Proliferation 1.98E-07 - 2.34E-03 87
Cellular Development 2.95E-07 - 2.44E-03 71
Cell Morphology 1.36E-06 - 2.44E-03 28
Associated Network Functions Score
Cellular Function and Maintenance, Hair and Skin 
Development and Function, Molecular Transport
39
Antigen Presentation, Cellular Movement, Genetic Disorder 38
Organ Morphology, Reproductive System Development and 
Function, Cancer 32
Cancer, Tumor Morphology, DNA Replication, 
Recombination, and Repair 27
Lipid Metabolism, Nucleic Acid Metabolism, Small Molecule 
Biochemistry 24
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Table 3.5 Table of Up-regulated and Down-regulated genes 
associated with cell death pathways 
 
IPA Analysis of DEG found in ST PMNs compared to MT PMNs that have been shown to be associated 
with cell death pathways.   
  
Up-regulated Apoptosis  
Associated Genes 
Down-regulated Apoptosis  
Associated Genes 
PTGS2 PCSK6 DFF40 HCK 
ATP2B1 COL18A1 MAPK9 APBB3 
IL12B CSF1 FOS JNK 
CXCL8 SELS LTB STIP1 
FBXW7 TLR2 CAD DDB2 
NFKB1A SFRP1 UCP2 BAX 
BCL2A1 PLAUR PGL2 GAPDH 
CCL3 PTPRE ARRB2 GCLC 
SFRS5 EPHA2 A2M S100A8 
CDKN1A KSR1 TXNDC17 CCNL2 
KAT5 EIF2AK3 EGLN2 CDK5R1 
RBL1 TNIP EGR1 DDX5 
NSMCE1 MYLK MLL CD47 
ATM HDAC3 CEBPD HMGB2 
ATR LMNB1 GADD45A ATF4 
TMEM102 NDEL1 DUSP1 YY1 
TXNRD1 PTPRCAP RARA ITPRP 
NDUFV2 CDH5 NFKB1 MAPK10 
IL1RN MSN HSPA1A CGT 
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Table 3.6 Table of Up-regulated and Down-regulated genes 
associated with inflammatory response pathways 
 
 
IPA Analysis of DEG found in ST PMNs compared to MT PMNs that have been shown to be associated 
with inflammatory response pathways. 
 
 
Up-regulated 
Immune Associated 
Genes 
Down-regulated 
Immune Associated 
Genes 
PTGS2 FOS 
IL12B JNK2 
CCL20 SLC39A1 
CXCL8 LTB 
CCL3 HCK 
NFKB1A CEBPD 
CXCL5 RARRES2 
MHCII RARA 
PSMD3 NFKB1 
IL1RN AKNA 
TLR2 IFI30 
SELS TOB1 
HLA-DQB1 IFNGR2 
PLAUR S100A8 
SLC11A1 CFP 
  ARRB2 
  MAPK10 
  MHC1 
  NMI 
  HSPA1A 
 
 
 
 
 
 
 
  
 51 
 
 
 
 
Fig 3.8  Genes Associated with Apoptosis 
 
IPA Analysis of DEG found in ST PMNs compared  to MT PMNs that have been shown to be associated 
with cell death pathways.  Up-regulated genes are shown in red, down-regulated genes are shown in 
green.  Depth of colour indicates level of relative expression, stronger colours = greater differential 
expression.   DEG arranged based on where they are known to occur: from top of graphic: extracellularly, 
within the cell membrane (blue bi-layer), within the cytoplasm and associated to mitochondria (central 
pink coloured organelle) and within the nucleus (brown oval). 
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Fig 3.9 Potential Apoptotic Pathway Affected by Exposure to the Supernatant of S. uberis 
0140J milk-culture 
 
Speculative pathway of DEG involved in apoptotic pathway based on cross-referencing between IPA 
pathways and KEGG pathways. Up-regulated genes are shown in red, down-regulated genes are shown in 
green.  Depth of colour indicates level of relative expression, stronger colours = greater differential 
expression.  Grey outlined (no fill) are present in the bovine, grey filled in shapes are present in the 
bovine & on the CAFG BloPlus microarray slide. Black dashed outlines signify products known in other 
species (principally human) but not seen/yet discovered in the bovine. 
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3.4.4 Proportion of Apoptotic and Dead Cells in the PMN Population Following 
Incubation in S. uberis 0140J Milk Culture Supernatant Compared to 
Incubation in Milk 
 
Analysis of the DEG identified by the microarray analysis indicated that genes involved in 
apoptotic pathways were differential expressed between the two groups.   
 
During apoptosis, phosphatidylserine (PS) translocates from the inner to the outer leaf of the 
phospholipid bilayer.  Annexin-V binds to phospholipids containing PS with high affinity.  As 
the Annexin-V is conjugated with the fluorochrome Fluorescein isothiocyanate (FITC), 
Annexin-V labelled cells are detected in the FL1-H channel by FACs.  As cells die, P.I. is able 
to enter the cell and bind DNA.  P.I. fluoresces in the FL2-H channel. 
 
PMNs isolated, as previously, from 3 animals were incubated in either milk (MT) or S. uberis 
0140J milk culture supernatant (ST) for 2 hrs and then labelled with Annexin V-FITC and P.I 
(Fig3.10 (a) and (b)).  The population of ST PMNs had significantly less apoptotic cells 
compared to the MT PMN population (24% (SD 2.7) Vs 42% (SD 8.1).  The proportion of 
dead cells was also lower in the ST PMN population (0.57% (SD 0.13) Vs 1.64% (SD 1.46)) 
(Fig 3.10(c)). 
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Fig 3.10  FACs Results for PMNs Incubated in Milk or S. uberis 0140J Milk Culture 
Supernatant. 
 
(a) and (b) show FACs plots of PMNs incubated in milk or culture supernatant respectively.  The 
percentage of cells represent in each quadrant is noted.  Cells positive for Annexin V-FITC, are appear in 
the lower right quadrant. Cells positive for both Annexin V-FITC and P.I. appear in the upper right 
quadrant.  (c) shows the combined data (n=3).  Live, non-apoptotic cells are shown in the lower left 
quadrant of the FACs plots, apoptotic cells are in the lower right quadrant and dead cells in the upper 
right quadrant. ST PMNs have a lower proportion of apoptotic cells than MT PMNs (p<0.01). 
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3.4.5 Validation of Microarray data by qPCR 
To validate the microarray findings q-PCR was performed on six of the identified DEG, using 
three potential housekeeping gens as reference.  Results for COX-2 are shown here.  
 
Fig 3.12  Transcript levels of COX-2 relative to 3 Potential Housekeeping genes in MT 
and ST PMNs  
qPCR was used to validate the microarray findings.  The mean transcript levels of COX-2 from 3 
DQLPDOV¶301VZHUHDVVHVVHGXVLQJDȕ-actin, (b) GAPDH and (c) boRPL2 as the housekeeping (HK) 
gene.  
 
 
 
 
 
  
(a) 
(c) 
(b) 
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Fig 3.11 Relative abundance of known constitutively expressed endogenous genes 
identified in previous studies to assess their ability to act as housekeeping genes for q-
PCR. 
The RNA expression of PMNs from 3 animals that were exposed to milk (Milk Txt), the supernatant of 
0140J milk cultures (Super Txt), and the 0140J milk culture supernatant that had been previously frozen 
(frozen ST) are shown. (a) shows abundance of ȕ-actin relative to boRPL2, (b) GAPDH relative to 
boRPL2 and (c) ȕ-actin relative to GAPDH.  If the two compared genes are constitutively expressed, then 
for each animal PMNs the relative abundance should be constant in all the test conditions.   
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4 Discussion 
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Streptococcus uberis is a leading cause of mastitis worldwide impacting on all dairy husbandry 
practice (Leigh, 1999). This economically important disease appears uncontrolled by current 
hygiene methods (Bradley, 2002), and worryingly its incidence may be increasing (Bradley et 
al., 2007). 
 
With this mounting disease challenge and public concern over the routine use of antibiotic 
treatments in the farming industry (NMCRC, 2004), novel methods are sought to control this 
pathogen; these include vaccination and immune-modulatory therapies (Denis et al., 2009, 
Wedlock et al., 2008).  To permit the development of these, further knowledge of the 
interactions between host and pathogen is crucial. 
 
After the initial penetration of a pathogen past the physical barriers of the streak canal, its 
presence is recognised by sentinel leukocytes and the mammary epithelial cells.  These release 
cytokines to initiate a leukocyte influx from the blood led, and dominated by, neutrophils.  The 
primary function of neutrophils is to phagocytose invading pathogens but it is increasingly 
recognised that they are crucial in signalling to other cells, directing the progression and 
resolution of the immune response (Whale and Griebel, 2009, Nathan, 2006).   
 
The interactions of virulent S. uberis 0140J and bovine PMNs has been a focus of much 
research.  Previous work has shown that during experimental challenge despite their large 
numbers, no PMNs appear to internalize S. uberis (Thomas et al., 1994). In vitro studies with 
S. uberis have shown the pathogen releases a soluble factor that inhibits the phagocytic 
function of blood-derived PMNs; this inhibition is associated with altered PMN cytoplasmic 
and membrane structure (Field et al., 1997).   However, the inhibitory substance remains 
unidentified and the mechanisms by which it alters PMN function and structure are unknown.  
This work set out to elucidate a better understanding of this host-pathogen interaction; firstly 
by assessing if avirulent strains of S. uberis were killed by PMNs, and secondly by measuring 
changes in the transcriptome of PMNs after exposure to this unknown inhibitory factor. 
 
4.1 Excluding the Mutant Lacking sub1095, the Growth of S. uberis 
0140J, EF20and Mutant Strains Lacking Vru, SrtA and sub1045, 
sub1154 are Similar in THB and Milk Cultures 
 
All strains of S. uberis tested grew to similar levels in THB, although the mutant lacking 
sub1095 had a slower rate of growth.  In milk, all reached a similar level except for the mutant 
lacking sub1095, which grew less well.  In the host this mutant, which lacks a collagen-like 
protein, initially colonizes the udder like the virulent 0140J, but after 24hr its numbers decline 
(Leigh et al., 2010), whether its reduced growth in vitro is related to its decreased 
pathogenicity is not yet determined. 
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4.2 The Attenuation of S. uberis EF20, and Mutants Lacking Vru, 
sub0145, sub1095 and sub11454 is Not Due to Susceptibility to 
Killing by PMNs 
 
The wild type S. uberis strain EF20 and mutants of S. uberis 0140J lacking: Vru, sub0145, 
sub1095 or sub1154 failed to establish the severe clinical infection seen following infection 
with the virulent strain S. uberis 0140J (Leigh et al., 2010, Leigh et al., 1990).  Whether 
attenuation of any of these mutants was due to decreased resistance to killing by PMNs was 
unknown.  In this study, the populations of these strains after culture in milk were not 
decreased by the presence of PMNs.   The absence of susceptibility to the bactericidal action of 
PMNs implies that in no instance was attenuation likely to be due to removal by PMNs.  
 
To confirm that the lack of susceptibility to the bactericidal actions of PMNs is due to a similar 
inhibition of the phagocytic function as occurs with 0140J and not due to, for example 
bacterial avoidance of opsonisation, the phagocytic assay of E. coli after incubating PMNs in 
milk pre-conditioned by the growth of these attenuated strains should be conducted.  
 
4.3 The Inhibitory Effect of Supernatant of S. uberis 0140J Milk 
Cultures on PMNs is Not Affected by Storage at -80°C 
 
The identity of the soluble factor which mediates inhibition of phagocytosis by PMNs is 
unknown.  Previously however, it has been shown that this effect is present in milk culture 
supernatant after removal of S. uberis (Field et al., 1997).  Given the inherent variability of the 
composition of milk between cows and over time, creating a standardised experimental model 
is challenging.  To permit a more consistent experimental design, the effect of freezing (and 
thus storage of) the supernatant of S. uberis milk cultures was investigated.  PMNs from six 
animals were incubated in both fresh supernatant from S. uberis 0140J milk culture (milk 
VXSHUQDWDQW ³06´ DQG WKH VDPH VXSHUQDWDQW WKDW KDG EHHQ IUR]HQ DQG WKHQ WKDZHG IUR]HQ
PLON VXSHUQDWDQW ³)06´   %RWK 06 DQG )06 ZHUH VKRZQ WR VLJQLILFDQWO\ LQKLELW WKH
bactericidal actions of PMNs (p<0.01**).  Although it appeared that MS was slightly more 
effective at inhibiting PMNs than FMS, there was no statistically significant difference.  This 
confirms that freezing does not affect the inhibitory action of the supernatant from S. uberis 
milk cultures, allowing a stock of MS to be made, stored frozen and used for various 
experiments over time. 
 
 
4.4 The Supernatant of S. uberis 0140J Culture Grown in RPMI is Not a 
Useful Model of the Inhibition of Bactericidal Actions of PMNs 
 
If S. uberis produced the soluble factor that causes the inhibitory effect on PMNs in a 
standardised commercial available media it would be globally useful, enabling the 
experimental design of such studies to be consistent between laboratories. To assess the 
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possibility of this, the inhibitory effects of the supernatant of S. uberis grown in RPMI tissue 
media culture were assessed.   
 
In RPMI, S. uberis grew to a final cell density of 2-8 x 108cfuml-1, ten-fold greater than its 
growth in milk.  Although the bactericidal action of PMN incubated in fresh or frozen 
supernatant of S. uberis 530,FXOWXUHV³56´DQG³)56´UHVSHFWLYHO\ZDVOHVVWKDQLQ530,
this was not statistically significant.  This suggests that, despite a S. uberis population ten 
times greater than that in milk, the inhibitory substance is produced at a much lower level, if at 
all. The possibility also remains that the inhibitory activity was derived from milk itself 
through the action of S. uberis; this was not investigated in the present study.   
 
 
4.5 Transcriptional Changes of PMNs Exposed to the Supernatant of S. 
uberis 0140J Milk Culture  
 
4.5.1 Experimental Design 
 
Microarray analysis is a useful tool to assess changes across the transcriptome (Allison et al., 
2006). In the bovine, it has been used to address a wide range of scientific questions including 
investigations into mammary gland function and host response to mastitis (Connor et al., 2008, 
Moyes et al., 2009, Swanson et al., 2009). 
 
The Centre for Animal Functional Genomics (CAFG) at Michigan State University (MSU) 
(http://www.cafg.msu.edu/) have developed the BloPlus Oligo microarray which encompasses 
genes known to be associated with the immune response, and has been used to investigate 
transcriptional changes in leukocytes associated with infectious disease (Verschoor et al., 
2010). 
 
The microarray slide contains 8400 70-mer oligonucleotides, printed in duplicate, each of 
which represents a single gene.  With an oligonucleotide probe length of 70 base-pairs (bp), 
the BloPlus array has superior specificity compared with the widely used Affymetrix 
GeneChip Bovine Genome Array which uses a probe length of 25bp 
(http://www.affymetrix.com). Although the GeneChip array is more comprehensive with 
probes for 23,000 bovine transcripts the BloPlus microarray includes probes for more recently 
discovered gene products, including highly relevant TLR transcripts.  The BloPlus array was a 
more appropriate tool to use than a genome wide chip given the incomplete status of the 
current bovine genome assembly, the greater probe specificity, more updated probe design and 
the focus on genes relevant to the immune systems. Although the genome-wide chip may have 
produced more data, without annotation the conclusions achievable would be limited. 
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This experiment assessed the differences  in transcription between  PMNs incubated in milk 
³PLON ±WUHDWHG´ 07 PMNs)) and  supernatant from S. uberis 0140J milk cultures 
³VXSHUQDWDQW-WUHDWHG´67 PMNs) from healthy lactating heifers.     
 
4.5.2 The Implications of the Differentially Expressed Genes Identified 
Although the transcriptional changes detected were small, the observation that only 328 (4% of 
the oligos expressed on the BloPlus Array these data suggest that only specific genes were 
affected by exposure to the supernatant of S. uberis milk culture. Further analysis using IPA 
Ingenuity analysis revealed several pathways and processes in which multiple DEG occur, 
indicating that these may be functionally relevant during the initial interaction with S. uberis 
and possibly the early stages of intramammary infection. 
 
4.6 Cellular Functions Affected 
 
4.6.1 Down-Regulation of Genes Involved in Apoptosis 
 
Individual PMNs undergo apoptosis to control their own death and identify themselves for 
uptake by macrophages.  This leads to their removal from the milieu without discharging their 
cytotoxic contents and internalised pathogens, and thus preventing further tissue damage.  
Apoptosis plays a crucial role in resolving the inflammatory response. As well as bringing 
about their own removal, apoptotic cells modify macrophage transcription to produce the anti-
inflammatory cytokines IL-10 and TGF-ȕ(Voll et al., 1997).  Progression of apoptosis directly 
correlates to loss of PMN function (Whyte et al., 1993), and is accompanied by characteristic 
morphological changes including fragmentation of chromatin, condensation of cytoplasmic 
contents and blebbing of the cell membrane (Reed, 2000). 
 
Nearly a quarter of all DEG identified by IPA analysis were associated with cell death.  DNA 
Fragmentation Factor 40 (DFF40), also known as Caspase-activated DNase (CAD), is an 
endonuclease activated by Caspase 9.  It is specific for double stranded DNA and brings about 
the fragmentation of DNA (Widlak, 2000). DFF40 was the most down-regulated gene in ST 
cells, potentially indicating a strong anti-apoptotic response after exposure to the supernatant 
of S. uberis milk culture.  Other down-regulated genes with crucial roles in the apoptotic 
pathway are transcription initiators, FOS and MAPK8 and 9 (also known as JNK and 
JNK2/SAPK respectively). 
 
The effect on apoptotic pathways was verified functionally by the Annexin-V FITC Apoptosis 
assay.  This assay showed a highly statistically significant difference in the ST PMNs which 
had approximately half the number of apoptotic cells compared to the MT PMNs (p<0.01), and 
after the 2hr incubation period the number of ST cells staining positive for propidium iodide, 
and therefore classed as dead, was only 1/8th  of that of MT cells. 
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4.6.1.1 Does Down-Regulation of Apoptosis Benefit the Host or the Pathogen? 
This observed effect corroborates in vivo work demonstrating that mastitis pathogens stimulate 
a decrease in the proportion of apoptotic lymphocytes (Slama et al., 2009, Sladek and 
Rysanek, 2001).  Human neutrophils also showed decreased apoptosis and prolonged half life 
following stimulation with Streptococcus haemoliticus (Colotta et al., 1992). 
 
Whether the apoptotic state observed favours the host or the pathogen is dependent on the 
nature and stage of the complex interactions between host and pathogen.  Later in the 
progression of an infection, it would be beneficial for a PMN which has ingested several 
pathogens to rapidly apoptose to ensure the removal of itself and hence the contained bacteria 
from the local environment, this has been shown to occur in human PMNs after uptake of 
bacterial pathogens (Kobayashi et al., 2003).  Other pathogens are able to manipulate apoptosis 
to promote their own survival and replication cycle; for example virulent Mycobacterium 
tuberculosis which is able to survive within macrophages disrupts the normal progression of 
apoptotic cell death in favour of necrosis which aids its spread within tissues (Gan et al., 
2008). 
 
The human pathogen S. pyogenes shows resistance to phagocytosis (Voyich et al., 2004) and 
the ability to survive intracellularly (Medina et al., 2003).  S. pyogenes modulates apoptosis in 
human neutrophils differently to other human pathogens,  by down-regulating genes associated 
with the IFN response and by up-regulating pro-apoptotic genes (Kobayashi et al., 2003).  
Although some common features exist between the findings of Kobayashi et al. and  those 
from this study, PMN exposed to S. uberis culture supernatants showed a down- (rather than 
up-) regulation of apoptosis.  IPA analysis identified 77 differentially expressed genes 
associated with cell death.  However, molecules in pathways were not concomitantly up- and 
down-regulated in association with their neighbours; this may be a reflection of either the 
complexity and subtlety of the system or of responses of contaminating cells disrupting the 
evidence of pathways in neutrophils. 
 
4.6.2 Inflammatory Pathways Affected 
 
Several genes involved with inflammatory pathways were differential expressed. Although 
coherent pathways could not be identified the modulation of transcription of several key 
players in the immune response increases the likelihood that these DEG are relevant to the 
interaction of S. uberis with host cells, but further work is required to confidently define their 
roles. 
 
4.6.2.1 Pro-inflammatory cytokine expression is up-regulated 
Increases in cytokine  expression are associated with mastitis infections, with some pathogen-
specific patterns (reviewed (Bannerman, 2009)).  In the present study expression of the 
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cytokines CXCL8, IL-12 , CCL20 CXCL5 and CCL3 were all up-regulated in ST PMNs.  
Inflammatory cytokines are produced by leukocytes, including neutrophils; a principal role of 
some cytokines is as chemokines.  They attract other leukocytes to the site of inflammation 
and their induced expression directs the resulting immune response.   
 
CXCL-8 (IL-8) acts as an attractant for neutrophils and monocytes and is also able to activate 
neutrophils; it is produced by many cells, including neutrophils, and is a key pro-inflammatory 
cytokine.  It has previously been shown to be up-regulated in experimental infections with S. 
uberis 0140J (Bannerman et al., 2004a) and it was the top up-regulated DEG in mammary 
tissue following infection with S. uberis (Moyes et al., 2009). 
 
IL-ȕLV WKHSVXEXQLW that heterodimerises with the p38 subunit to form the active dimer 
IL-12 and is also part of the IL-23 heterodimer.  Cells of the monocyte lineage are the main 
producers of IL-12ȕ, however PMNs have been shown to produce IL-12 (reviewed by  
(Scapini et al., 2000)). The overwhelming presence of PMNs during mastitis suggests they 
could significant contribute to the ongoing immune response.  IL-WULJJHUVDQ,)1ȖUHVSRQVH
in immune cells and is important in the defence against intracellular pathogens, mediating a 
Th1 response (Scapini et al., 2000).  Bannerman and colleagues found that experimental 
infection with S. uberis 0140J increases levels of IL-12 which correlates with ,)1Ȗproduction 
(Bannerman et al., 2004a). 
 
IL-23, initially shown to be produced by activated dendritic cells (Oppmann et al., 2000),  
activates a neutrophil-mediated response via IL-17 leading to IL-1, IL-6 and TNFĮ  release 
(Langrish et al., 2004).  Whether the IL-ȕ transcription detected by microarray is directed 
via IL-12 or IL-23 cannot be determined, in fact it is likely that both are relevant as in any 
inflammatory process the resulting immune response is due to the balance between many pro 
and anti-inflammatory molecules.  In experimental challenge, IL-ȕ levels increases in 
response to S. uberis strain 0140J, but not in response to strain EF20 (Coffey et al personal 
communication).  However, the increase in response to 0140J is much less than with the 
attenuated mutant strains lacking SrtA and Vru (Coffey et al personal communication). Even 
during infection in vivo, where numerous cytokines were measured, it is hard to definitively 
link the levels of IL-ȕ seen with biological function.  As a general trend, increases in IL-ȕ 
SURGXFWLRQFRUUHODWHZLWK71)Į,/-8 and initially bacterial numbers in the udder, but IL-ȕ 
negatively correlates with IL-6, perhaps indicating an overall anti-inflammatory bias in its 
effect. Though some parallels may be drawn between the data generated from in vivo and in 
vitro studies, with regards to Il-ȕSURGXFWLRQWKHH[DFWFRQWULEXWLRQRI,/-12 is clouded by 
the fact that the IL-ȕVXEXQLWLVFRPPRQWRERWK,/-12 and IL-23. The contribution of IL-23 
to the immune response to infection must therefore be investigated to assess the role of IL-23 
during experimental challenge. 
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CCL20, DOVRWHUPHGPDFURSKDJHLQIODPPDWRU\SURWHLQĮ0,3-Į, is a chemoattractant for 
neutrophils and lymphocytes but not monocytes. CCL20 mRNA and protein has been detected 
in human neutrophils as have transcripts for CCR6, the CCL20 receptor (reviewed by 
(Schutyser et al., 2003)). Human CCL20 has been shown to have a direct antimicrobial action 
against several pathogens including streptococci (Yang et al., 2003), although the activity of 
bovine CCL20 against S. uberis is unknown, it is an interesting finding to explore further. 
4.6.2.2 Increased Expression of Toll-Like Receptor 2 (TLR2) 
TLR2 gene expression was up-regulated. Bovine TLR2 is a PRR important in binding the 
peptidoglycan of Gram-positive bacteria (Werling et al., 2006).  Following mastitis infection 
due to various pathogens, TLR2 transcription has been shown to be up-regulated in infected 
quarters (Goldammer et al., 2004); in NEB (compared to PEB) cows TLR2 transcription also 
increases in circulating PMNs following intramammary infection with S. uberis (Moyes et al., 
2010a).  Although TLR2 activation can promote transcription of the cytokines that were also 
up-regulated (described previously, Section 4.6.2.1), key intermediates (i.e. MyD88) were not.  
It is therefore likely that increased transcription of TLR2 was in response to the stimulation of 
the PMNs. However due to the early time point investigated this did not yet equate to 
increased expression of the receptor, and thus the TLR2 pathway had not yet been activated.  
This illustrates the caution required when trying to relate transcriptional expression with the 
resulting pathway activation and protein and functional changes. 
 
4.6.2.3 Altered Transcription of MHC in ST PMNs 
Transcription of the Major Histocompatibility Group II (MHCII) transcription was increased 
whilst MHCI transcription decreased.  MHCII is responsible for antigen presentation in 
professional APCs.  Some recent work suggests that PMNs may be able to take up MHCII 
from apoptotic and necrotic cells though no evidence was found to support constitutive MHCII 
expression by PMNs (Whale et al., 2006a) which has been suggested by some work with 
human PMNs (Gosselin et al., 1993). 
 
4.6.3 Bivalent Cations may be Important in Interactions Between S. uberis and the 
Host 
 
Expression of SLC40a1, also known as ferroportin, was down-regulated in the ST cells.  Iron 
is an essential trace element for both microbes and vertebrates, Various host defences, 
including lactoferrin and lipocalin and ferroportin exist that sequester iron, rendering it 
unavailable for microbial metabolism (Ganz, 2009).  Ferroportin is a membrane protein 
identified in macrophages and epithelial cells which exports iron out of the cell.  It is also a 
receptor for the hormone hepicidin; the activity of which leads to internalization and 
breakdown of ferroportin. This results in the retention of iron in the cytoplasm as ferritin, thus 
is decreasing iron availability for extracellular pathogens.  A TLR-4-dependent down-
regulation of ferroportin was detected in macrophages (but not in non-myeloid cells) in 
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response to bacterial pathogens in a murine model (Peyssonnaux et al., 2006), and was 
postulated to favour successful defence against extracellular pathogens.   
 
If the differential expression of ferroportin in the present study was due to contaminating 
macrophages within the cellular population isolated from blood, then the mechanisms 
underlying its down-regulation may be more complicated.  It is known that macrophages, 
unlike neutrophils, are capable of phagocytosing S. uberis (Grant R.G, 1996).  Under these 
conditions, higher intracellular iron availability is beneficial to the pathogen, providing it is 
accessible to the phagosome. Neisseria meningitidis  is capable of initiating ferritin breakdown 
in infected epithelial cells  (Larson et al., 2004). Importantly ferroportin transcription in murine 
macrophages with mycobacterial-infected phagosomes was shown to be directed by the 
presence of the pathogen (Van Zandt et al., 2008). Various streptococci have been reported to 
manipulate the host cell after phagocytosis to benefit their own survival and replication (Quach 
et al., 2009, Phelps and Neely, 2007). The iron transporter within S. suis has been shown to be 
crucial to intracellular survival and pathogenesis (Aranda et al., 2009).   
 
The zinc transporter SLC39A1 (ZIP) was also down-regulated in the present study.  
Knowledge of the importance of zinc during infection is limited; however its acquisition has 
been shown to be essential for virulence of S. pyogenes (Weston et al., 2009).  Crystallization 
of the S. pyogenes laminin-binding protein reveals it targets zinc, and it is thought that it 
mediates invasion via adhering to zinc-bound laminin (Linke et al., 2009).   
 
The microarray results obtained in this study highlight the requirement for further investigation 
into the mechanisms of bivalent cation metabolism in both the success of pathogen and of host 
defences with regards to infection with S. uberis. 
 
Although there is no clear answer to the underlying basis of the reduction in the bactericidal 
function of PMN, the microarray analysis has revealed evidence that S. uberis manipulates the 
host response and has provided an initial insight into the possible early stages of the host 
pathogen interactions. 
 
4.6.4 Influence of Incubation Period  
 
Following experimental challenge it has been reported that bacterial numbers typically 
increase to around 107 cfu ml-1 from time of challenge to 24hr post infection. The SCC 
typically remained at the pre-infection level until the second milking after infection (at 24hr).  
This reflects the influx of PMNs from the blood by that time point.  Both bacterial and PMN 
levels remained elevated over the subsequent milkings and remained elevated until the onset of 
clinical signs.   PMN functionality has been shown to be rapidly compromised after exposure 
to S. uberis 0140J (J.A. Leigh, unpublished data).  
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The aim of this project was to look at the earliest time points in the interaction between PMNs 
and pathogen.  The experiment was designed to mimic the 24hr time point of in vivo S. uberis 
0140J challenge.   
 
This project showed that strains of S. uberis grow to around 107 cfu ml-1 in overnight milk 
cultures. These cultures were then filtered to generate the supernatants.  Incubating the PMNs 
in the supernatants for 120min aimed to reproduce the level of bacteria-derived soluble factors 
that these cells would be exposed to in vivo, and also to expose them to it for a length of time 
known to result in loss of PMN bactericidal activity.  The microarray analysis investigated the 
transcriptional changes that may contribute to this loss of functionality.   
 
In this study, 120min was chosen as the time point at which to assess transcriptional changes in 
ST exposed PMNs based on preliminary phagocytic assays in milk cultures showing that 
bacteria susceptible to phagocytosis were reduced to 10% of their original population by 
90min and 0.1% by 120min.  As this study aimed to understand the early interactions between 
products of S. uberis and PMNs, 120min was a justified time point to investigate by 
microarray. 
 
In phagocytic assays with human PMNs and various human bacterial pathogens, only S. 
pyogenes showed resistance to the phagocytic actions of PMNs (Kobayashi et al., 2003).  
90min post challenge, 65% of S. S\RJHQHVZHUHYLDEOHZKLOVWRWKHUSDWKRJHQV¶ VXUYLYDOZDV
<20%.  Interestingly this coincided with S. pyogenes- challenged PMNs having two and half 
times more DEG compared to those challenged by all other pathogens, and a very different 
transcriptional profile.  S. pyogenes-challenged PMNs had differential expression of genes 
associated with apoptotic pathways; many of which were also differentially expressed in this 
study.  However, the S. pyogenes-challenged PMNs had an accelerated rate of apoptosis 
compared to PMNs challenged with other pathogens (Kobayashi et al., 2003).  This would 
suggest that although S. pyogenes and S. uberis are resistant to the phagocytic actions of 
PMNs, the process of events following the interaction in the PMNs is very different.  
Nevertheless the evidence from Kobayashi et al and the results of this study show that 
interactions at the time point chosen for this study are relevant to unravelling the early 
interactions between streptococcal pathogens and PMNs. 
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4.6.5 Validation of Microarray Data 
 
To investigate if the DEG identified by the microarray hybridisation technique are 
corroborated by other recognised and routinely used techniques, qPCR, ELISA as well as the 
apoptotic cell assay previously discussed, were used. 
 
Real-time polymerase chain reaction (qPCR) is a sensitive and specific technique that is often 
used for the validation of microarray data  (Rajeevan et al., 2001). In this study, qPCR was 
performed on those genes which were seen to be amongst the ones most differentially 
expressed and where assays for detection were already available. As a result five DEG were 
further analysed, including COX-2, CXCL-8, IL-ȕDQG&&/ZKLFKDOORFFXULQWKHWRS
up- regulated genes in ST PMNs. 
  
qPCR results for COX-2, CXCL-8, IL-ȕ, CCL20 and 1).ȕ, normalised to ȕ-actin, boRPL2 
and GAPDH, showed no correlation with the findings of the microarray data. Results for 
COX-2 are shown, this was the third highest up-regulated DEG identified by microarray in ST 
PMNs a finding not supported by qPCR.  Several factors may be responsible for this finding, 
RNA degradation lead to an incomplete data set for all transcripts for all of the 6 animals used 
for qPCR. In addition, wide biological variation and inevitable variation if the amount and type 
of contaminating cells within the isolated PMN population (see below) lead to mixed results. 
In addition, levels of IL-ȕ DQG &&/ ZHUH WRR ORZ WR EH DFFXUDWHO\ TXDQWLILHG by the 
qPCR, suggesting at this early time point (2hr) transcriptional changes are below the level of 
detection of the available assays.   
 
Also the use of ȕ-actin, boRPL2 and GAPDH as housekeeping genes is questionable. Indeed ȕ-
actin and GAPDH were found as DEG on the microarray. boRPL2 was identified as a HK 
from in-vivo microarray analysis of 0140J mammary gland infection, however none of these 
three appeared consistently endogenously expressed in this work.  
 
ELISAs were used to investigate if the transcriptional up-regulation of CXCL8 and IL-ȕ 
identified by microarray was reflected at the protein level.  However, cytokine levels were 
below the detection range of the technique (results not shown). 
 
The Annexin-V apoptotic assay showed a significantly lower percentage of apoptotic cells in 
the ST PMN population compared to the MT PMNs; excitingly, this correlates well with the 
down-regulation of genes associated with the apoptotic pathways, giving confidence in the 
validity of the DEG found relating to this pathway. 
 
Future optimisation of various aspects of the experiment (discussed below) should lead to 
increased sensitivity of the techniques and reliability of results, improving the likelihood of 
successful validation of the microarray findings. 
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4.7 Factors Affecting the Lack of Statistical Significance 
 
Microarrays are a fairly new technique and no flawless statistical algorithm to handle the large 
amount of data for all experimental designs has yet been developed.  A p-value of <0.05 
(which was the value used to identify DEG in this study) assumes each test was carried out 
separately and indicates a 5% chance of that result being a false positive.   However, the 
microarray technique seeks to test many hypotheses, and in this case explores the differential 
transcription of 8,400 features simultaneously. The effect of multiplicity increases the chances 
of those DEG being deemed false positive.  In an attempt to overcome this effect, a False 
'LVFRYHU\5DWHIGUDGMXVWPHQWLVURXWLQHO\PDGH 7KLVJHQHUDWHVDQ³DGMXVWHGS-YDOXH´IRU
the DEG which takes into account the data, number of hypotheses being tested and the number 
of experimental replicates (Pawitan et al., 2005).  An fdr of 5%, as was used here, attributes 
equivalent significance to a result of p<0.05 if only a single hypothesis was tested. For the 
DEG found here the adjusted p±values were 0.99, indicating no statistical significance.  
Several reasons may underlie this observed lack of statistical relevance and these are discussed 
further (below). 
 
4.7.1 The Number of Genes Differentially Expressed is Low 
 
Three hundred and twenty-eight differentially Expressed Genes (DEG) were identified with a 
p-value of <0.05, this represented 4% of the oligos expressed on the BloPlus Array. As only 
4% of all oligos (328 out of 8400) were differentially  detected, with an fdr of 5% it is 
impossible to differentiate true positive from false positive results, and hence in such a 
situation the resulting adjusted p-value would always appear non-significant.  The inability of 
fdr adjustments to identify DEG when only a small proportion of tested gene products are 
differential expressed is an on-going drawback (Rajeevan et al., 2001).  In these cases, DEG 
can still be significant and biological knowledge of what would be expected to be affected, 
over representation in specific pathways and validation by other tests can aid in identifying 
true positive results.  Furthermore, although not a good indication of true significance in 
systePVZLWK³EDFNJURXQGQRLVH´www-stat.stanford.edu/~tibs/ftp/FCTComparison.pdf), fold 
changes are a useful guide and DEG with a high fold change value are more likely to be 
biologically significant.  In this study only 36 out of the 328 DEG had a fold change greater 
than two.   
 
4.7.2 Suboptimal Number of Biological Replicates  
 
It is widely suggested that a minimum of five biological replicates are optimal when designing 
microarray studies (Allison et al., 2006), and the experiment was designed to sample seven 
animals.  Animals were selected for use based on NMR records to ensure no present or recent 
history of disease, as the transcriptome of circulating PMNs is altered in disease states and 
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NEB (Moyes et al., 2010a).  Unfortunately issues with acute mastitis and other concurrent 
diseases on the day of blood sampling, time and licence limitations (on the number animals to 
be used) and degradation of RNA samples reduced the number of suitable animals to four. In 
an attempt to overcome the issue with limited biological replicates, the microarray design 
incorporated ³dyeswaps´ whereby the same sample was used for two separate arrays, with the 
sample labelled with each of the two microarray dyes. 
 
4.7.3 Potential Effects of Contaminating Cell Types 
 
Historically PMNs were considered to have limited transcriptional potential, though those 
working with PMNs would debate this (Nathan, 2006).  These cells are reported to have 1/10th 
to 1/20th of the total RNA content of other cells (Cassatella, 1995).  Thus, the contribution of 
contaminating cells to the overall RNA levels is potentially more of an issue for studies of 
PMNs than for other cell population. The purity of the isolated cell population was 94.8% 
(n=4, SD 0.83); if PMNs have a RNA content 1/10th of other cells then PMN-derived RNA 
could account for 65% of the total RNA.  If the PMN RNA content is 1/20th compared to other 
cells then PMN-derived RNA would only account for 48% of the total RNA.  
 
7KHGHILQLWLRQ³301´FDQEHXQFOHDU  ,W LVXVHG LQWHUFKDQJHDbly ZLWK WKH WHUP³QHXWURSKLO´
EXWLVDOVRDQXPEUHOODWHUPHTXLYDOHQWWR³JUDQXORF\WH´:LWKUHVSHFWWRWKLVVWXG\, the actual 
³301´ SRSXODWLRQ ZDV D JUDQXORF\WH SRSXODWLRQ DV WKH LVRODWLRQ WHFKQLTXH GLG QRW
differentiate between neutrophils, eosinophils and basophils.  However, the aim of the project 
was to investigate the interactions of S. uberis and neutrophils; in functional studies the 
presence of a low level of contaminating eosinophils and basophils would not impact on the 
results, however with studies into gene expression the composition of the population should be 
acknowledged. 
 
The contribution of eosinophils to the PMN population is highly variable between individuals 
(see Table 4.1) and thus will influence the relative quantity of RNA from each cell type 
between animals.  The presence of eosinophils in the PMN population was indicated during 
FACs by high autofluorescence of some cells (Shapiro, 2003). 
 
 
Table 4.1 Reference intervals for clinically healthy lactating dairy cows 
Table adapted from Brun-Hansen et al., 2006; values calculated from samples from 75 animals. 
Granulocyte cells/L
Neutrophils 1.3-5.3 x 109
Eosinophils 0.1-1.7 x 109
Basophils 0-0.1 x 109
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Several methods for isolating neutrophils from whole blood exist and debate surrounds the 
most appropriate method to derive the cells without influencing functionality and limiting the 
effects of contaminating cells. The major contaminating cells are thought to be monocytes and 
lymphocytes (Soltys et al., 1999), and the presence of cells other than neutrophils potentially 
impacts on transcriptional studies. 
 
In this study it is unknown what, if any, changes the isolation technique may have induced in 
the PMNs, but taken in context it is not a major concern.  The effect of contaminating cell 
types however should be considered in future experimental design; it is inevitable that in this 
study the RNA would not have been entirely derived from neutrophils.  High expression of 
SLC40A1 (ferroportin) by macrophages and enterocytes cells is well documented (Anderson 
and Vulpe, 2009), though no evidence has been presented for its production by PMNs 
(Peyssonnaux et al., 2006).  Its occurrence in the top fifteen down-regulated genes in ST cells 
is possible evidence that contaminating cells are contributing to the transcripts being analysed.  
Thus, the differentially expressed genes identified may reflect changes in cell types other than 
neutrophils.  
 
The use of different gradient techniques to isolate human neutrophils (Percoll, Ficoll-
Hypaque/Dextran sedimentation, Mono-Poly Resolving Medium) (Venaille et al., 1994) all 
yielded  a population of equivalent purity (93-94%) and viability (98%) as the technique 
employed in this study.  It is clear that groups have varying success with implementing 
established isolation techniques. The continual Percoll density gradient technique yielded 
bovine neutrophil purities of  81% +/- 3% (Soltys et al., 1999), >87% (Van Oostveldt et al., 
2002), 94% (Wang et al., 2009)  and  >95% (Rinaldi et al., 2007).   
 
Methods implementing erythrocyte lysis achieved PMN populations of 90% (Van Oostveldt et 
al., 2002) and 94.8 % in this study. Hypotonic shock, using ammonium-chloride or water is a 
standard technique to lysis erythrocytes; however this has been suggested to affect 
functionality by altered transcription of cell surface receptors (Macey et al., 1995, Youssef et 
al., 1995). 
  
Clearly, established techniques for PMN isolation although adequate for functional studies 
have limitations when used to isolate cells for microarray analysis.  Future studies would 
benefit from investigating novel PMN isolation techniques, and three methods which merit 
further investigation are suggested below. 
 
Following whole blood lysis, the use of anti-bovine neutrophil specific monoclonal antibody 
labelled biomagnetic beads resulted in a neutrophil population of 95.5% +/- 1.8% purity and a 
marked decrease in the level of contaminating leukocytes and monocytes with no detrimental 
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effects on neutrophil functionality (Soltys et al., 1999), although effects on the transcriptome 
were not assessed. 
 
Neutrophils have a very high expression of the )FȖ5,,,% &'E VXUIDFH UHFHSWRU ZKLFK
binds pathogen-bound immunoglobulin.  Combining a discontinuous Percoll gradient and 
FACs sorting of cells positive for CD16bright  a 99.9% pure human neutrophil population with a 
viability of 90% was achieved (Lichtenberger et al., 1999), the authors suggest that this 
method enables RNA studies to confidently assess transcriptional changes in neutrophils.  
Whether this method could be adapted for successful bovine neutrophil isolation is unknown. 
 
Suitable reagents are not always available for bovine studies, as they are for human or murine 
studies, and this can have implications for studies. In addition, markers suitable for identifying 
neutrophils in the human system do not necessarily hold true for isolating the equivalent cell 
population in other systems, such as the bovine. Using FACsAria technology, populations of 
cells can be isolated based on the forward and side scatter patterns without the need for cell 
markers.  Forward scatter correlates to increasing cell diameter and side scatter correlates with 
the granularity of a cell.  PMNs are large granular cells, which produce a scatter profile 
different to other leukocytes, allowing their differentiation.  Using this, it may be possible to 
remove the contaminating cells from the granulocyte population. 
 
Clearly, isolating a pure population of neutrophils is a technical hurdle that affects human and 
animal research worldwide; however now it is acknowledged and improved isolation 
techniques are being developed. 
 
4.8 Concluding Remarks 
 
PMNs lack bactericidal efficacy against avirulent strains of S. uberis, as has previously been 
shown with virulent S. uberis 0140J.  This suggests that the virulence determining genes 
vru(encoding a DNA binding gene regulator), sub0145 (encoding a putative lactoferrin binding 
protein), sub1095 (encoding a collagen-like protein) and sub1154 (encoding a serine protease 
with limited homology to C5a peptidase) are important for other host-pathogen interactions.  
 
Soluble factors produced by virulent S. uberis 0140J in milk alter the transcriptome in a 94.8% 
pure PMN population.  The transcription of apoptotic mediators is down-regulated and 
functionally it is seen that PMNs exposed to the supernatant of S. uberis milk cultures have a 
significantly reduced proportion of apoptotic cells compared to those in milk. Transcription 
from pro-inflammatory cytokines LQFOXGLQJ&;&/,/ȕDQG CCL20 are up-regulated and 
genes involved in cellular structure and metabolism had altered levels of expression in PMNs 
exposed to soluble factors from S. uberis.  This project provides initial insights into the 
mechanisms by which S. uberis elicits changes in PMNs that may relate to inhibition the 
bactericidal function and / or other host pathogen interactions.  
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6.1 Appendix 1 - Reagents. 
 
 
Re: 2.1.1 - Isolation of Bovine Blood derived Neutrophils (PMNs) 
 E.D.T.A. (1.5%) in PBS. 
  EDTA    1.5 g 
  NaCl    0.7 g 
  Phosphate buffer (0.132M) 10 ml 
  Make up to 100 ml with H2O. 
 
 0.132M Phosphate Buffer, pH6.8 
  Na2HPO4 (mol. wt. 141.96)  18.74 g/l 
  KH2PO4 (mol. wt. 136.09)  17.96 g/l 
  Mix 1l of each to give pH 6.8 
 
 2.7% NaCl/ PO4 
  NaCl    2.7 g 
  0.132M PO4   10 ml 
  Make up to 100 ml with H2O. 
 
Filter all solutions through a 0.22µm filter. 
 
 
 
Re: 2.5.5 RNA Preparation for Microarray & Hybridization 
Medium Stringency buffer (1litre) 
 20 x SSC Ultra Pure  100ml 
 10% SDS   10ml 
 DEPC     890ml 
 
High Stringency buffer (1litre) 
 20 x SSC Ultra Pure  5ml 
 10% SDS   5ml 
 DEPC     990ml 
 
Post Wash buffer (1litre) 
 20 x SSC Ultra Pure  5ml 
 DEPC     995ml 
 
1% SDS (1litre) 
 10% SDS   100ml 
 DEPC     900ml 
 
Filter all solutions through a 0.22µm filter. 
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6.2 Appendix 2 
List of all Differential expressed Gene (p<0.05) in PMNs incubated in the supernatant of S. uberis 0140J milk cultures compared to PMNs incubated in Milk 
 
 
ID Name logFC P.Value adj.P.Val Gene Product PubMed Identifier  
TC280060 Bt00008300 2.0522307 0.040084281 0.9999 Bos taurus suppressor of Ty 3 homolog (S. cerevisiae) (SUPT3H),  8464 
TC279698 Bt00002046 1.7950908 0.018053657 0.9999 
Bos taurus pyridine nucleotide-
disulphide oxidoreductase domain 2 
(PYROXD2) 
84795 
TC301115 BLO_ext_00249 1.7280485 0.006239608 0.9999 
Bos taurus prostaglandin-
endoperoxide synthase 2 
(prostaglandin G/H synthase and 
cyclooxygenase) (PTGS2), mRNA  
5743 
TC278334 Bt00000010 1.5980438 0.02904543 0.9999 
Bos taurus ATPase, Ca++ 
transporting, plasma membrane 1 
(ATP2B1 
490 
TC303286 BLO_ext_00813 1.5646392 0.04802556 0.9999 Bos taurus interleukin 12 40kDa 
subunit (IL12p40) mRNA, complete  3593 
TC348871 BLO_ext_00089 1.3904423 0.00476398 0.9999 
Bos taurus solute carrier family 7 
(cationic amino acid transporter, y+ 
system), member 5, mRNA  
8140 
TC320367 BLO_ext_00127 1.3263098 0.046256221 0.9999 
PREDICTED: Bos taurus HLA-B 
associated transcript 2-like, transcript 
variant 4 (BAT2), mRNA  
7916 
TC362166 BLO_ext_01361 1.2962611 0.008482366 0.9999 CCL20 6364 
TC346213 BLO_ext_00260 1.2773858 0.02618509 0.9999 
??? - Homo sapiens carnitine 
palmitoyltransferase 1A (liver) 
(CPT1A) 
1374 
CN787616 BLO_ext_01516 1.2392781 0.006917831 0.9999 Bos taurus interleukin 8 (IL8), mRNA 3576 
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TC365520 BLO_ext_00097 1.226677 0.006796437 0.9999 PREDICTED: Bos taurus B42b-like (SPIB),  6689 
TC264195 Bt00005205 1.1518548 0.009446591 0.9999 
PREDICTED: Bos taurus MAP 
kinase-activated protein kinase 2-like 
(MAPKAPK2) 
9261 
TC384398 BLO_ext_01021 1.1334783 0.002169498 0.9999 
Bos taurus StAR-related lipid transfer 
(START) domain containing 7 
(STARD7),  
56910 
TC354007 BLO_ext_01171 1.1197955 0.038996093 0.9999 Bos taurus MAP kinase interacting 
serine/threonine kinase 1, mRNA  8569 
TC334872 BLO_ext_00311 1.1052077 0.005323652 0.9999 Bos taurus BCL2-related protein A1 (BCL2A1),  597 
TC349142 BLO_ext_01212 1.0927079 0.018205712 0.9999 8.??? 
 
TC292818 Bt00008064 1.0916935 0.000754145 0.9999 Bos taurus nuclear receptor 
coactivator 7, mRNA   
TC280954 Bt00001344 1.0915865 0.031019769 0.9999 Bos taurus F-box and WD repeat domain containing 7 (FBXW7),  55294 
TC302319 BLO_ext_00786 1.0758957 0.020024842 0.9999 Interleukin-8 precursor (IL-8) (CXCL8), complete 3576 
TC292252 Bt00007056 1.0669116 0.011466072 0.9999 Bos taurus heterogeneous nuclear 
ribonucleoprotein D-like 9987 
TC265449 Bt00007449 1.0622141 0.027935873 0.9999 ??? 
 
TC265112 Bt00007566 1.0580219 0.011788877 0.9999 Bos taurus zinc finger RAD18 domain-containing protein C1orf124  83932 
TC334872 BLO_ext_01835 1.052336 0.006706473 0.9999 Bos taurus BCL2-related protein A1 (BCL2A1),  597 
TC265095 Bt00000915 1.0268989 0.032225057 0.9999 Bos taurus Src-like-adaptor (SLA) 6503 
TC332609 BLO_ext_01039 1.0190973 0.000469653 0.9999 Bos taurus chemokine (C-C motif) ligand 3 (CCL3), mRNA 6348 
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TC270521 Bt00001042 1.0069137 0.012528668 0.9999 
PREDICTED:Bos taurus class E 
basic helix-loop-helix protein 22-like 
(LOC100438493) 
525275 
TC346994 BLO_ext_01667 1.0054223 0.00866878 0.9999 
Bos taurus acetyl-CoA 
acetyltransferase 1 (ACAT1), nuclear 
gene encoding mitochondrial protein, 
mRNA  
38 
TC288064 Bt00005066 1.0040587 0.016166023 0.9999 Bos taurus serine/arginine-rich 
splicing factor 5 (SRSF5) 6430 
TC288300 Bt00001362 0.9767791 0.011219578 0.9999 Bos taurus cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) 1026 
TC261806 Bt00007981 0.9336074 0.02414013 0.9999 Other spp similar to casein kinase 1, 
alpha 1  1452 
TC278999 Bt00006894 0.9315588 0.001122346 0.9999 
Bos taurus casein kinase 1, alpha 1, 
mRNA (cDNA clone MGC:133860 
IMAGE:8051424), complete cds 
120321 
TC332683 BLO_ext_00608 0.9274987 0.033139069 0.9999 
Bos taurus nuclear factor of kappa 
light polypeptide gene enhancer in B-
cells inhibitor, alpha (NFKBIA) 
4792 
TC262404 Bt00002862 0.9254754 0.019746054 0.9999 PREDICTED: Bos taurus sorting 
nexin 9-like (SNX9) 51429 
TC277342 Bt00001336 0.9145378 0.015380305 0.9999 
Bos taurus v-maf musculoaponeurotic 
fibrosarcoma oncogene homolog F 
(avian) (MAFF) 
23764 
TC279100 Bt00004054 0.9050894 0.002262304 0.9999 Bos taurus transglutaminase 3  343641 
TC319160 BLO_ext_01071 0.8924126 0.009932955 0.9999 
Homo sapiens nuclear casein kinase 
and cyclin-dependent kinase substrate 
1 (NUCKS1) 
64710 
TC277780 Bt00002608 0.8859808 0.002137444 0.9999 Bos taurus non-SMC element 1 homolog (S. cerevisiae) (NSMCE1) 197370 
TC304649 BLO_ext_01821 0.8802318 0.012424566 0.9999 Bos taurus golgin A4 (GOLGA4) 2803 
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3X SSC 3X SSC 0.8695549 0.044369335 0.9999 
  
TC291688 Bt00000692 0.8334175 0.006691278 0.9999 Bos taurus chemokine (C-X-C motif) ligand 5, mRNA 6374 
TC378794 BLO_ext_01689 0.8318371 0.022507824 0.9999 Bos taurus casein alpha s1,  1446 
TC263414 Bt00004612 0.8313134 0.01750988 0.9999 
PREDICTED: Pan troglodytes zinc 
finger protein 253, transcript variant 2 
(ZNF253) 
56242 
TC359843 BLO_ext_00151 0.8095987 0.016634319 0.9999 Bos taurus retinoblastoma-like 1 (p107) (RBL1) 5933 
TC266431 Bt00007563 0.8081819 0.010549532 0.9999 92% Smad nuclear interacting protein 1  79753 
TC359669 BLO_ext_00845 0.806265 0.0069572 0.9999 
voltage-dependent anion channel 3 
[Bos taurus] /Bos taurus voltage-
dependent anion channel 5, 
pseudogene  
7419 
TC317663 BLO_ext_00877 0.8024091 0.0425046 0.9999 
PREDICTED: Bos taurus 
Monofunctional C1-tetrahydrofolate 
synthase, mitochondrial-like   
TC298822 Bt00008022 0.7930591 0.0280594 0.9999 Bos taurus diacylglycerol kinase, eta (DGKH) 160851 
TC276581 Bt00007282 0.7852402 0.00051026 0.9999 
NADH dehydrogenase subunit 2 [Bos 
taurus]/ complete mitochondrion 
genome seq 
4729 
TC326824 BLO_ext_01169 0.7680174 0.008777257 0.9999 
Bos taurus major histocompatibility 
complex, class II, DQ beta (BOLA-
DQB), mRNA 
282495 
TC289830 Bt00003423 0.755799 0.003740602 0.9999 Bos taurus RAB14, member RAS 
oncogene family (RAB14),  51552 
TC326320 BLO_ext_00930 0.7421851 0.000917231 0.9999 ??? 
 
TC278934 Bt00004972 0.720156 0.039009542 0.9999 PREDICTED: Bos taurus Nipped-B homolog (Drosophila) (NIPBL) 25836 
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TC262379 Bt00007677 0.7160329 0.001282366 0.9999 
Bos taurus proteasome (prosome, 
macropain) 26S subunit, non-ATPase, 
3 (PSMD3), mRNA 
5709 
TC277642 Bt00001170 0.7160173 0.001726741 0.9999 Bos taurus sushi-repeat-containing protein, X-linked  27286 
TC279132 Bt00008005 0.7094219 0.012421132 0.9999 Bos taurus RAN binding protein 2 (RANBP2) 5903 
TC305737 BLO_ext_00124 0.7024293 0.037976841 0.9999 Bos taurus signal recognition particle 19kDa (SRP19) 6728 
TC366499 BLO_ext_00946 0.688937 0.021677628 0.9999 rnmt 8731 
TC306072 BLO_ext_00612 0.6881203 0.012169581 0.9999 Bos taurus solute carrier family 38, 
member 2 (SLC38A2) 54407 
TC260344 Bt00001246 0.684884 0.038892513 0.9999 Bos taurus erythrocyte membrane protein band 4.9 (dematin) 2039 
TC291405 Bt00002559 0.6841295 0.015152115 0.9999 
PREDICTED: Bos taurus protein 
tyrosine phosphatase type IVA, 
member 1, transcript variant 2 
(PTP4A1) 
7803 
TC347387 BLO_ext_00456 0.6810544 0.017158257 0.9999 Bos taurus K(lysine) acetyltransferase 5 (KAT5) 10524 
TC298968 Bt00003685 0.6581573 0.015263877 0.9999 
71% similar to: Canis familiaris 
chromosome 26, clone XX-367D6, 
complete sequence 
340654 
TC313034 BLO_ext_01275 0.6509534 0.021389524 0.9999 Bos taurus ubiquitin specific peptidase 11 8237 
TC260940 Bt00007469 0.6498008 0.041152369 0.9999 
Bos taurus potassium channel 
tetramerisation domain containing 15 
(KCTD15) 
79047 
TC362744 BLO_ext_01658 0.6488661 0.012155731 0.9999 Homo sapiens SERTA domain 
containing 2 (SERTAD2) 9792 
TC267196 Bt00004993 0.647851 0.049748232 0.9999 PREDICTED: Bos taurus homer protein homolog 3-like (LOC508124) 508124 
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TC323641 BLO_ext_00465 0.6360772 0.032382225 0.9999 
PREDICTED: Bos taurus ARF 
GTPase-activating protein GIT1-like 
(GIT1) 
28964 
TC264549 Bt00006500 0.63593 0.015205072 0.9999 Bos taurus BCL2-related protein A1 (BCL2A1) 597 
TC289705 Bt00003058 0.6321312 0.018169028 0.9999 
Bos taurus mitochondrial succinate 
dehydrogenase complex subunit D 
(SDHD) 
6392 
TC263726 Bt00006196 0.6290897 0.028248065 0.9999 
Bos taurus chromosome 12 open 
reading frame 57 ortholog 
(C5H12ORF57) 
511545 
TC283458 Bt00007526 0.6254424 0.009216017 0.9999 82% Homo sapiens forkhead transcription factor (FREAC2) gene  
TC321111 BLO_ext_01808 0.6198772 0.047385229 0.9999 
PREDICTED: Bos taurus 
chromodomain helicase DNA binding 
protein 4 (CHD4) 
1108 
TC277709 Bt00006694 0.6173853 0.00180441 0.9999 
PREDICTED: Bos taurus lysine (K)-
specific demethylase 1A, transcript 
variant 2 (KDM1A), mRNA 
23028 
TC307794 BLO_ext_00022 0.6161659 0.011491206 0.9999 
similar to UP|CDNA_FELCA 
(O19002) Cyclin-dependent kinase 
inhibitor 1 (p21) (CDK-interacting 
protein 1), partial (98%) 
1026 
TC277533 Bt00000093 0.6147841 0.016434199 0.9999 Bos taurus thioredoxin reductase  7296 
TC276739 Bt00007335 0.6066081 0.025945593 0.9999 Bos taurus legumain 5641 
TC263382 Bt00006019 0.5990663 0.037692544 0.9999 Bos taurus solute carrier family 38, 
member 2 (SLC38A2) 54407 
TC260762 Bt00002208 0.5974352 0.034369367 0.9999 Homo sapiens SERTA domain 
containing 2 (SERTAD2),  9792 
DV918751 BLO_ext_01547 0.5906311 0.033918712 0.9999 PREDICTED: Bos taurus ataxia telangiectasia mutated-like (ATM) 472 
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TC296578 Bt00006431 0.5871703 0.034103824 0.9999 Bos taurus transmembrane protein 102 (TMEM102) 284114 
TC289042 Bt00003852 0.5847657 0.018074799 0.9999 
PREDICTED: Bos taurus zinc finger 
and BTB domain containing 3-like 
(LOC508118) 
79842 
TC280297 Bt00004505 0.581536 0.003986521 0.9999 
PREDICTED: Bos taurus protein 
tyrosine phosphatase, receptor type, 
E, transcript variant 2 (PTPRE) 
5791 
TC301906 BLO_ext_01328 0.5795819 0.001566504 0.9999 Bos taurus interleukin 1 receptor 
antagonist (IL1RN),  3557 
TC265123 Bt00004614 0.574353 0.020646968 0.9999 Other spp. myosin light chain kinase 4638 
TC293956 Bt00005119 0.5736674 0.013978743 0.9999 ankyrin repeat and BTB (POZ) domain containing 2 [Homo sapiens]  25841 
TC294454 Bt00000791 0.5669323 0.036388279 0.9999 ??? 
 
TC290846 Bt00004551 0.5609159 0.036052021 0.9999 
PREDICTED: Bos taurus FGFR1 
oncogene partner-like 
(LOC100335363) 
11116 
TC292089 Bt00005055 0.5581411 0.007360991 0.9999 
Bos taurus solute carrier organic 
anion transporter family, member 
2A1 
6578 
TC304070 BLO_ext_00869 0.5510144 0.047726196 0.9999 
Other sppPREDICTED: Sus scrofa 
extracellular related kinase 3 
(SUSERK3),  
5597 
TC265010 Bt00004149 0.5487082 0.035476272 0.9999 Bos taurus MAX interactor 1 (MXI1) 4601 
TC274338 Bt00002597 0.5472316 0.011889706 0.9999 Bos taurus collagen, type XVIII, 
alpha 1 80781 
TC291913 Bt00004741 0.5462598 0.005573802 0.9999 5.??? 
 
TC294158 Bt00005118 0.543254 0.019178307 0.9999 Bos taurus solute carrier 11A1 (SLC11A1) gene 6556 
TC320323 BLO_ext_00112 0.5401201 0.012077176 0.9999 Bos taurus bone morphogenetic protein 2 656 
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CK773489 Bt00002391 0.5373134 0.005987278 0.9999 
PREDICTED: Bos taurus Deafness, 
autosomal recessive 31-like 
(LOC533033), / CASK-interacting 
protein CIP98 [Bos taurus]  
25861 
TC265064 Bt00007559 0.5368674 0.018137527 0.9999 PREDICTED: Bos taurus tubulin folding cofactor E-like (TBCEL) 219899 
TC293460 Bt00008147 0.5308719 0.004260563 0.9999 RNF41 10193 
CK770390 Bt00000685 0.5287193 0.040274386 0.9999 Bos taurus CD34 molecule (CD34),  947 
TC290083 Bt00005798 0.5274001 0.022604405 0.9999 Bos taurus osteoclast stimulating factor 1 1435 
TC294150 Bt00006108 0.5240385 0.023787474 0.9999 Bos taurus transmembrane protein 177 (TMEM177) 80775 
TC314145 BLO_ext_01339 0.5238979 0.028721657 0.9999 Bos taurus hypothetical LOC510651 510651 
TC369042 BLO_ext_01249 0.5238581 0.043110665 0.9999 ??? 
 
TC307162 BLO_ext_00327 0.5146834 0.003662182 0.9999 Bos taurus insulin induced gene 1 (INSIG1) 3638 
TC289830 Bt00007491 0.5085601 0.004191556 0.9999 Bos taurus RAB14, member RAS 
oncogene family (RAB14),  51552 
TC290924 Bt00002022 0.490484 0.029481937 0.9999 Bos taurus plasminogen activator, 
urokinase receptor (PLAUR) 5329 
TC290573 Bt00007320 0.4904174 0.039275487 0.9999 Bos taurus SEC11 homolog A (S. 
cerevisiae) 23478 
TC281731 Bt00004401 0.489582 0.013922257 0.9999 
PREDICTED: Canis familiaris 
similar to nuclear receptor co-
repressor/HDAC3 complex subunit, 
transcript variant 1 (LOC488176) 
8841 
TC278673 Bt00008280 0.4886953 0.033155971 0.9999 Bos taurus cadherin 5, type 2 (vascular endothelium) (CDH5) 1003 
TC279228 Bt00006291 0.4755307 0.031682125 0.9999 Bos taurus cannabinoid receptor interacting protein 1 (CNRIP1) 25927 
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TC279696 Bt00008215 0.4752285 0.00859445 0.9999 
Bos taurus nudE nuclear distribution 
gene E homolog (A. nidulans)-like 1 
(NDEL1), mRNA  
81565 
DT820236 BLO_ext_01531 0.4734749 0.015547697 0.9999 
PREDICTED: Bos taurus ataxia 
telangiectasia and Rad3 related 
(ATR) 
545 
TC277492 Bt00006592 0.4552978 0.023020835 0.9999 Bos taurus myotubularin related protein 3 (MTMR3) 8897 
TC305384 BLO_ext_00658 0.4532279 0.042194582 0.9999 PREDICTED: Bos taurus hypothetical protein LOC613429  613429 
TC262059 Bt00003062 0.4505764 0.034122291 0.9999 Bos taurus lamin B1 (LMNB1) 4001 
TC284094 Bt00003543 0.448504 0.048112873 0.9999 Bos taurus G protein-coupled receptor 18 (GPR18) 2841 
TC268008 Bt00007440 0.4478432 0.029033915 0.9999 Bos taurus zinc finger protein 18 (KOX 11) (ZNF18),  7566 
TC263932 Bt00006407 0.4466628 0.023951848 0.9999 Bos taurus cyclin-dependent kinase 2 interacting protein (CINP) 51550 
TC349688 BLO_ext_01240 0.4429201 0.049297324 0.9999 
PREDICTED: Bos taurus proprotein 
convertase subtilisin/kexin type 6 
(PCSK6) 
5046 
BM251455 BLO_ext_01575 0.4393582 0.010285485 0.9999 
Bos taurus protein tyrosine 
phosphatase, receptor type, C-
associated protein (PTPRCAP) 
5790 
TC263033 Bt00006867 0.4380581 0.02023723 0.9999 Bos taurus UBA domain containing 1 (UBAC1) 10422 
TC263222 Bt00006950 0.4377182 0.049323562 0.9999 
PREDICTED: Bos taurus 
transcription elongation factor A 
protein-like 8-like (LOC100335186) 
100335186 
TC262573 Bt00008277 0.4347916 0.013965235 0.9999 Bos taurus olfactomedin-like 3 (OLFML3),  56944 
TC270316 Bt00001549 0.4336504 0.031607555 0.9999 Bos taurus sex comb on midleg-like 4 (Drosophila) (SCML4) 256380 
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TC276127 Bt00007155 0.4322309 0.016522082 0.9999 Bos taurus coatomer protein complex, 
subunit alpha (COPA) 1314 
TC278493 Bt00000165 0.4321336 0.033993263 0.9999 Bos taurus spectrin repeat containing, 
nuclear envelope 1, 23345 
TC296368 Bt00000034 0.4286303 0.040573844 0.9999 
PREDICTED: Bos taurus 
hypothetical LOC507299 
(LOC507299) 
507299 
TC301109 BLO_ext_01778 0.4267886 0.045047759 0.9999 Bos taurus toll-like receptor 2 (TLR2) 7097 
TC261604 Bt00000750 0.4227565 0.01460475 0.9999 
PREDICTED: Bos taurus protein 
disulfide isomerase family A, 
member 6 (PDIA6), 
10130 
TC264274 Bt00000252 0.4200305 0.032406568 0.9999 
Bos taurus chromosome 3 open 
reading frame 39 (C3orf39)/ 
glycosyltransferase [Bos taurus] 
84892 
TC291993 Bt00005117 0.4182977 0.02275651 0.9999 Bos taurus mannosidase, alpha, class 2C, member 1 (MAN2C1) 4123 
TC312374 BLO_ext_00131 0.4174013 0.045543371 0.9999 PREDICTED: Bos taurus FLJ00400 protein-like (TMC8) 147138 
TC280157 Bt00002801 0.4169272 0.040063378 0.9999 
PREDICTED: Bos taurus 
tetratricopeptide repeat domain 28 
(TTC28) 
23331 
TC281731 Bt00007917 0.416927 0.031671762 0.9999 
PREDICTED: Canis familiaris 
similar to nuclear receptor co-
repressor/HDAC3 complex subunit, 
transcript variant 1 (LOC488176) 
79718 
TC277255 Bt00005123 0.4152404 0.024357395 0.9999 Bos taurus COMM domain 
containing 3 (COMMD3) 23412 
TC294239 Bt00006180 0.4125064 0.040376154 0.9999 
Bos taurus nuclear fragile X mental 
retardation protein interacting protein 
1 (NUFIP1) 
26747 
TC262843 Bt00006904 0.4074794 0.024155087 0.9999 Bos taurus OCIA domain containing 1 54940 
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TC262230 Bt00007369 0.4074427 0.025768525 0.9999 
Bos taurus solute carrier family 37 
(glycerol-3-phosphate transporter), 
member 3 (SLC37A3) 
84255 
TC263467 Bt00001189 0.4062924 0.048663943 0.9999 Bos taurus G protein beta subunit-like 64223 
TC309408 BLO_ext_00350 0.4046797 0.035454655 0.9999 Bos taurus secreted frizzled-related protein 1 (SFRP1) 6422 
TC279126 Bt00006978 0.4020171 0.020740456 0.9999 PREDICTED: Bos taurus ash2-like (ASH2L) 9070 
TC284722 Bt00003124 0.3992534 0.039188484 0.9999 ??? 
 
TC264888 Bt00006779 0.3956723 0.032487294 0.9999 
Bos taurus ariadne homolog, 
ubiquitin-conjugating enzyme E2 
binding protein, 1 (Drosophila) 
(ARIH1) 
25820 
TC284191 Bt00002937 0.3887799 0.048124581 0.9999 Bos taurus G protein-coupled receptor 19 (GPR19) 2842 
TC341560 BLO_ext_00533 0.3834356 0.020327497 0.9999 
PREDICTED: Bos taurus TNFAIP3 
interacting protein 2-like 
(LOC100336382) 
79155 
TC292506 Bt00000646 0.3831918 0.036502415 0.9999 
PREDICTED: Bos taurus malignant 
fibrous histiocytoma amplified 
sequence 1-like (LOC782395) 
9258 
TC281577 Bt00004382 0.3792729 0.020099955 0.9999 Bos taurus zinc finger CCCH-type 
containing 12A (ZC3H12A) 80149 
TC269681 Bt00007124 0.3748167 0.046639122 0.9999 Bos taurus moesin (MSN) 4478 
TC353647 BLO_ext_00966 0.3728141 0.032994735 0.9999 
Bos taurus eukaryotic translation 
initiation factor 2-alpha kinase 3 
(EIF2AK3) 
9451 
TC265861 Bt00005515 0.372731 0.028168676 0.9999 PREDICTED: Bos taurus kinase 
suppressor of ras-like (KSR1) 8844 
TC274336 Bt00008323 0.3711971 0.036557084 0.9999 Bos taurus cleft lip and palate 
associated transmembrane protein 1 1209 
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(CLPTM1) 
TC266323 Bt00004984 0.3693119 0.047191565 0.9999 Bos taurus exosome component 2 (EXOSC2) 23404 
TC263575 Bt00007132 0.3684037 0.039843822 0.9999 HLA-B associated transcript 5 [Bos taurus] 7920 
TC263160 Bt00006997 0.3616417 0.034469965 0.9999 Bos taurus phenylalanine hydroxylase (PAH) 5053 
CK776781 Bt00004226 0.3551084 0.049082729 0.9999 Bos taurus LIM homeobox 2 (LHX2) 9355 
TC278440 Bt00005750 0.3545765 0.035858413 0.9999 Bos taurus hypothetical protein LOC617407 (MYEOV2) 150678 
TC290661 Bt00000804 0.3498708 0.026883825 0.9999 Bos taurus selenoprotein S (SELS) 55829 
TC266895 Bt00004006 0.3477441 0.043885141 0.9999 
Bos taurus aminolevulinate, delta-, 
synthase 2 (ALAS2), nuclear gene 
encoding mitochondrial protein 
212 
TC294182 Bt00003131 0.3381972 0.043843573 0.9999 PREDICTED: Bos taurus Ephrin type-A receptor 2-like (EPHA2) 1969 
TC276619 Bt00001026 -0.3007036 0.046330664 0.9999 
Bos taurus proteasome activator 28 
alpha subunit (PSME1) 5720 
TC271006 Bt00000309 -0.308377 0.049769906 0.9999 PREDICTED: Bos taurus Protein SPT2 homolog (SPTY2D1) 144108 
TC277336 Bt00001294 -0.3109363 0.046404978 0.9999 
Bos taurus Protein FAM177A1 
(FAM177A1) 283635 
TC266737 Bt00001722 -0.3232869 0.043536817 0.9999 
Bos taurus retinol dehydrogenase 5 
(11-cis/9-cis) (RDH5) 5959 
TC264579 Bt00000415 -0.3307699 0.044876914 0.9999 
Bos taurus dual specificity 
phosphatase 26 (putative) (DUSP26) 78986 
TC277732 Bt00007545 -0.340751 0.041944263 0.9999 
similar to -linked N-
acetylglucosamine (GlcNAc) 
transferase (UDP-N-
8473 
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acetylglucosamine:polypeptide-N-
acetylglucosaminyl transferase)  
TC292021 Bt00004996 -0.3509704 0.032038455 0.9999 
Bos taurus LSM2 homolog, U6 small 
nuclear RNA associated (S. 
cerevisiae) (LSM2), mRNA 
57819 
TC290641 Bt00001448 -0.354034 0.043787281 0.9999 
Bos taurus intraflagellar transport 20 
homolog (Chlamydomonas), mRNA 
(cDNA clone :128507 
IMAGE:7984736), complete cds 
Length=1116  
90410 
TC295191 Bt00002594 -0.3595893 0.029622981 0.9999 
Bos taurus DEAD (Asp-Glu-Ala-
Asp) box polypeptide 25 (DDX25),  29118 
TC266660 Bt00000024 -0.3677349 0.028329748 0.9999 
Bos taurus megakaryocyte-associated 
tyrosine kinase (MATK), mRNA 4145 
CK772121 Bt00001655 -0.3746503 0.038865869 0.9999 
Bos taurus ELK4, ETS-domain 
protein (SRF accessory protein 1) 
(ELK4), mRNA 
2005 
TC262137 Bt00007214 -0.3761254 0.041268053 0.9999 
homologue to UP|O77972 (O77972) 
MHC class I antigen precursor, partial 
(94%) 
515712 
CK846934 Bt00005947 -0.3820454 0.048206147 0.9999 ???  
TC291215 Bt00000788 -0.391137 0.040626126 0.9999 
Bos taurus XIAP associated factor 1, 
mRNA (cDNA clone MGC:152158  
IMAGE:8401538), complete cds 
54739 
TC264026 Bt00000036 -0.3954973 0.022224638 0.9999 
Bos taurus YY1 transcription factor 
(YY1), mRNA 7528 
TC260259 Bt00007261 -0.3964111 0.045228977 0.9999 
similar to UP|Q96AQ3 (Q96AQ3) 
Activating transcription factor 4 
(ATF4 protein), partial (97%) 
468 
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TC274694 Bt00000319 -0.3995986 0.035331919 0.9999 
Bos taurus pre-B-cell leukemia 
homeobox interacting protein 1 
(PBXIP1), mRNA  
57326 
TC280483 Bt00001023 -0.4003575 0.023447415 0.9999 
Bos taurus mitogen-activated protein 
kinase 10 (MAPK10), mRNA 5602 
TC291256 Bt00006331 -0.4016636 0.030936768 0.9999 
Bos taurus cDNA clone 
IMAGE:8204390, **** WARNING: 
chimeric clone ****/neuroplastin[Bos 
taurus]  
27020 
TC332973 BLO_ext_00373 -0.4049599 0.045710582 0.9999 ???  
TC323485 BLO_ext_01377 -0.4067972 0.029863043 0.9999 ???  
TC375575 BLO_ext_01721 -0.4072243 0.039824431 0.9999 
Bos taurus thyroid hormone receptor 
interactor 12 (TRIP12), mRNA 9320 
TC289232 Bt00006991 -0.4086506 0.049622477 0.9999 
PREDICTED: Bos taurus 
glyceraldehyde-3-phosphate 
dehydrogenase-like, transcript variant 
2 GAPDH), mRNA Length=1321  
2597 
TC290662 Bt00008157 -0.4103671 0.022377858 0.9999 
Bos taurus DDB1 and CUL4 
associated factor 12 (DCAF12), 
mRNA Length=3606  
25853 
TC294903 Bt00001534 -0.4108721 0.04071321 0.9999 
PREDICTED: Bos taurus 
endoplasmic reticulum 
metallopeptidase 1 
ERMP1),mRNALength=3131  
79956 
TC293332 Bt00005116 -0.4156938 0.031938221 0.9999 
Bos taurus tetraspanin 2 (TSPAN2), 
mRNA 10100 
TC263111 Bt00005032 -0.4236258 0.030302973 0.9999 
Bos taurus selenoprotein W, 1 
(SEPW1), mRNA Length=975 6415 
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TC276886 Bt00000226 -0.4238415 0.014749543 0.9999 
B.taurus CI-19 mRNA for 19 kDa 
subunit of NADH:ubiquinone 
oxidoreductase complex complex I) 
Length=793  
4702 
TC290892 Bt00007027 -0.4240478 0.040408732 0.9999 
PREDICTED: Bos taurus cyclin L2 
(CCNL2), mRNA Length=2268 81669 
TC261318 Bt00007055 -0.4264981 0.046785748 0.9999 
similar to 
GB|AAC50817.1|1669498|HSU63420 
Sp140 protein {Homo sapiens;} , 
partial (36%) 
 
TC288347 Bt00003725 -0.4292927 0.04228924 0.9999 
similar to UP|RT12_MOUSE 
(O35680) 28S ribosomal protein S12, 
mitochondrial precursor (MPR-S12) 
(MT-RPS12), partial (79%) 
 
TC299695 Bt00001133 -0.4326274 0.026075278 0.9999 
Bos taurus enhancer of mRNA 
decapping 3 homolog (S. cerevisiae) 
(EDC3), mRNA 
80153 
TC279941 Bt00001258 -0.4419895 0.04244383 0.9999 
PREDICTED: Bos taurus arrestin, 
beta 2 (ARRB2), mRNA 
Length=2027 
409 
TC281108 Bt00002895 -0.4440237 0.007585969 0.9999 
PREDICTED: Bos taurus cartilage 
intermediate layer protein, nucleotide 
pyrophosphohydrolase-like 
(LOC100336614), miscRNA 
Length=4405  
8483 
TC260532 Bt00002710 -0.4442126 0.012324431 0.9999 
Bos taurus BCL2-associated X 
protein (BAX), mRNA 581 
TC277236 Bt00006928 -0.4499226 0.029739448 0.9999 
Bos taurus fucosidase, alpha-L- 1, 
tissue (FUCA1), mRNA 2517 
TC275397 Bt00005299 -0.4522479 0.027024798 0.9999 
Bos taurus damage-specific DNA 
binding protein 2, 48kDa (DDB2) 1643 
TC336987 BLO_ext_00935 - 0.033314767 0.9999 ??? 
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0.4562459 
TC316499 BLO_ext_01712 -0.4573851 0.026340669 0.9999 
Bos taurus complement factor 
properdin (CFP), mRNA 5199 
TC289844 Bt00000641 -0.4574335 0.037837545 0.9999 ???  
TC290803 Bt00000321 -0.4600286 0.018210341 0.9999 
Bos taurus nucleoporin 93kDa 
(NUP93), mRNA 9688 
TC302380 BLO_ext_00716 -0.4645305 0.026005616 0.9999 
Bos taurus RAB11B, member RAS 
oncogene family (RAB11B), mRNA 9230 
TC278232 Bt00005769 -0.4652662 0.049932706 0.9999 
Bos taurus chromosome 17 open 
reading frame 37 ortholog 
(C19H17orf37), mRNA 
505710 
TC274907 Bt00006659 -0.4658035 0.008099921 0.9999 
Bos taurus tubulin, alpha 4a 
(TUBA4A), mRNA 7277 
TC282581 Bt00005907 -0.4692216 0.019201868 0.9999 
Bos taurus protein arginine 
methyltransferase 3 (PRMT3), 
mRNA 
10196 
TC278690 Bt00003759 -0.4784624 0.030574211 0.9999 
Bos taurus NudC domain containing 
2, mRNA (cDNA clone MGC:157142  
IMAGE:8445848), complete cds 
Length=928 
134492 
TC279191 Bt00003812 -0.4837959 0.043958926 0.9999 
Bos taurus S100 calcium binding 
protein A8 (S100A8), mRNA 6279 
TC262912 Bt00001175 -0.4841372 0.012296855 0.9999 
Bos taurus GABA(A) receptor-
associated protein (GABARAP), 
mRNA 
11337 
TC352430 BLO_ext_01203 -0.4848352 0.004113953 0.9999 
Bos taurus nuclear factor of kappa 
light polypeptide gene enhancer in B-
cells 1, mRNA (cDNA clone 
MGC:159793 IMAGE:8566028), 
complete cds Length=4006  
4790 
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TC289914 Bt00005525 -0.4891006 0.037696196 0.9999 
PREDICTED: Bos taurus methyl-
CpG binding domain protein 2-like 
(LOC100337206), mRNA 
Length=1186  
8932 
TC278851 Bt00003119 -0.4938317 0.015021413 0.9999 
Bos taurus MID1 interacting protein 1 
(gastrulation specific G12 homolog 
(zebrafish)) (MID1IP1), mRNA  
58526 
TC274870 Bt00001766 -0.4971227 0.037268566 0.9999 
PREDICTED: Bos taurus 
hypothetical protein LOC507475 
(C2orf17),  mRNA Length=2830 
79137 
TC302757 BLO_ext_00973 -0.4978186 0.037386555 0.9999 
PREDICTED: Bos taurus high-
mobility group box 2-like 
(LOC618297), mRNA Length=1224 
3148 
TC277381 Bt00002702 -0.5108908 0.011758632 0.9999 
Bos taurus glutamate-cysteine ligase 
catalytic subunit (GCLC), MHC class 
II antigen 
2729 
TC265296 Bt00003835 -0.5112298 0.009942694 0.9999 thymosin beta 15a (TMSB15A) 11013 
TC340441 BLO_ext_00298 -0.5152751 0.030607327 0.9999 chk again 4067 
TC264146 Bt00001614 -0.5162334 0.020431182 0.9999 
Bos taurus GDP dissociation inhibitor 
1 (GDI1), mRNA 2664 
TC260186 Bt00006414 -0.5177554 0.010525536 0.9999 
Bos taurus DEAD (Asp-Glu-Ala-
Asp) box polypeptide 5 (DDX5), 
mRNA Length=2460 
1655 
3X SSC 3X SSC -0.5195017 0.037082798 0.9999   
TC294081 Bt00005512 -0.5212872 0.003411415 0.9999 
Bos taurus empty spiracles homeobox 
2 (EMX2), mRNA 2018 
TC331799 BLO_ext_00405 -0.5218898 0.025764253 0.9999 
Bos taurus inositol 1,4,5-triphosphate 
receptor interacting protein (ITPRIP), 
mRNA  
85450 
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TC261379 Bt00005603 -0.5219759 0.031048512 0.9999 
Bos taurus chromosome 10 open 
reading frame 58 ortholog 
(C28H10orf58), mRNA  
534049 
TC275669 Bt00006629 -0.5281892 0.035513335 0.9999 
Bos taurus dystrobrevin, beta 
(DTNB), mRNA Length=2236 1838 
TC290180 Bt00000320 -0.5326378 0.016398512 0.9999 
Bos taurus GLI pathogenesis-related 
2 (GLIPR2), mRNA 152007 
CK778581 Bt00005131 -0.5455767 0.049744792 0.9999 
 p25/p35=Cyclin-dependent kinase 5 
activator [cattle, brain, mRNA,  8851 
TC261722 Bt00003466 -0.5465393 0.002999324 0.9999 
PREDICTED: Bos taurus interferon 
gamma receptor 2 (interferon gamma 
transducer 1) (IFNGR2), mRNA 
Length=2450  
3460 
TC276804 Bt00000048 -0.5570155 0.035704122 0.9999 
Bos taurus FK506 binding protein 3, 
25kDa (FKBP3), mRNALength=965 2287 
TC278620 Bt00000858 -0.5594772 0.002686588 0.9999 
PREDICTED: Bos taurus transducer 
of ERBB2, 1, transcript variant 1 
(TOB1), mRNA Length=1624  
10140 
TC363120 BLO_ext_00141 -0.5619924 0.032330248 0.9999 
Bos taurus ribosomal protein SA, 
mRNA (cDNA clone MGC:127394 
IMAGE:7952265), complete cds  
3921 
TC277432 Bt00006028 -0.5625449 0.031165223 0.9999 
Bos taurus stress-induced-
phosphoprotein 1 (Hsp70/Hsp90-
organizing protein) (STIP1), mRNA  
10963 
3X SSC 3X SSC -0.5635035 0.03133276 0.9999   
TC290563 Bt00001647 -0.5675191 0.013714313 0.9999 
chk again - not on BLAST but on 
gene list as Yippee-like pr3/no match 
after SW chk  
TC266345 Bt00000060 -0.5701487 0.002729738 0.9999 
Bos taurus transducin (beta)-like 2 
(TBL2), mRNA 26608 
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TC355595 BLO_ext_01714 -0.570866 0.047894305 0.9999 
Bos taurus heat-shock 70-kilodalton 
protein 1A (HSPA1A) and heat-shock 
70-kilodalton protein 1B (HSPA1B) 
genes, complete  
3303 
TC292929 Bt00003987 -0.5803721 0.030769865 0.9999 
Bos taurus tRNA splicing 
endonuclease 2 homolog (S. 
cerevisiae), mRNA (cDNA clone 
MGC:166394 IMAGE:8479061), 
complete cds Length=2084  
80746 
TC292492 Bt00001330 -0.585259 0.038474826 0.9999 
PREDICTED: Bos taurus immediate 
early response 2-like 
(LOC100335829), mRNA 
Length=2143  
9592 
TC275351 Bt00000450 -0.5903565 0.021857794 0.9999 3.???  
TC318087 BLO_ext_01656 -0.5914872 0.03526453 0.9999 
Bos taurus alpha-2-macroglobulin 
(A2M), mRNA 2 
TC276744 Bt00005805 -0.5958061 0.034929901 0.9999 
PREDICTED: Bos taurus calmodulin 
2-like (LOC100297240), mRNA 
Length=1144  
805 
TC263098 Bt00005763 -0.5974019 0.032971675 0.9999 
Bos taurus citrate synthase (CS), 
nuclear gene encoding mitochondrial 
protein, mRNA 
1431 
TC289511 Bt00007216 -0.6038192 0.033482297 0.9999 
Bos taurus heat shock 70kDa protein 
1A (HSPA1A), mRNA 3303 
TC275352 Bt00004613 -0.6047629 0.02004654 0.9999 
PREDICTED: Bos taurus 
apolipoprotein L4-like (LOC518495), 
miscRNA Length=3360   
TC263733 Bt00001079 -0.6059492 0.025112101 0.9999 
Bos taurus gamma-inducible protein 
30 (IFI30), mRNA 10437 
TC274428 Bt00001352 -0.6067946 0.022800704 0.9999 
Bos taurus 
phosphatidylglycerophosphate 9489 
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synthase 1 (PGS1), mRNA 
Length=3584  
TC278133 Bt00002317 -0.6095712 0.029590218 0.9999 
Bos taurus CD47 molecule (CD47), 
mRNA 961 
TC264915 Bt00002146 -0.6118817 0.021423217 0.9999 2.???  
TC314950 BLO_ext_00459 -0.6178177 0.024966141 0.9999 
Bos taurus dCTP pyrophosphatase 1 
(DCTPP1), mRNA 79077 
TC367570 BLO_ext_01075 -0.6216882 0.010359661 0.9999 
Bos taurus golgi to ER traffic protein 
4 homolog (S. cerevisiae) (GET4), 
mRNA  
51608 
TC304483 BLO_ext_01612 -0.6245521 0.032378853 0.9999 
Bos taurus amyloid beta (A4) 
precursor protein-binding, family B, 
member 3 
10307 
TC291119 Bt00000333 -0.6284391 0.002451886 0.9999 
AT-hook transcription factor [Homo 
sapiens] 80709 
TC265246 Bt00004431 -0.6296791 0.040440466 0.9999 
 similar to DVL-binding protein 
DAPLE, transcript variant 1   
TC293478 Bt00003548 -0.6303222 0.012003873 0.9999 
Bos taurus myogenic factor 6 
(herculin), mRNA  4618 
TC267031 Bt00005887 -0.6310142 0.030484584 0.9999 
Bos taurus eukaryotic translation 
initiation factor 2C, 3 (EIF2C3)  
TC263181 Bt00007790 -0.6436186 0.049963773 0.9999 
PREDICTED: Bos taurus regulator of 
G-protein signaling 2-like (RGS2), 
mRNA 
5997 
TC263963 Bt00000584 -0.6454735 0.0043014 0.9999 
Bos taurus torsin family 1, member A 
(torsin A) (TOR1A),  1861 
TC265651 Bt00004882 -0.6551844 0.001143084 0.9999 
PREDICTED: Bos taurus retinoic 
acid receptor, alpha (RARA), mRNA 5914 
TC289553 Bt00003687 -0.6642732 0.025201282 0.9999 
os taurus retinoic acid receptor 
responder (tazarotene induced) 2 5919 
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(RARRES2), 
TC263767 Bt00004062 -0.6675882 0.023681324 0.9999 
PREDICTED: Bos taurus kinesin 
light chain 4 (KLC4), mRNA 89953 
TC285244 Bt00003573 -0.6704754 0.02273841 0.9999 
Bos taurus armadillo repeat 
containing 2 (ARMC2 84071 
Rn_Control_09 Rn_Control_09 -0.6705993 0.031543978 0.9999   
TC260214 Bt00003180 -0.6737341 0.035877591 0.9999 ???  
TC367139 BLO_ext_01030 -0.6738599 0.019160163 0.9999 
Bos taurus growth arrest and DNA-
damage-inducible, alpha, 1647 
TC267448 Bt00003475 -0.6801215 0.010472484 0.9999 
PREDICTED: Bos taurus zinc finger 
protein 76 (expressed in testis)-like 
(LOC100337287), mRNA  
7629 
TC278438 Bt00001802 -0.6827445 0.013894496 0.9999 
Bos taurus early growth response 1, 
mRNA  1958 
CK769831 Bt00000352 -0.682837 0.030741375 0.9999 ??? 
 
TC300762 Bt00003550 -0.684194 0.047569939 0.9999 
Bos taurus major facilitator 
superfamily domain containing 10-
like  
TC277110 Bt00003303 -0.6847696 0.001604192 0.9999 
Bos taurus chromosome 2 open 
reading frame 24 ortholog 507473 
TC274295 Bt00001718 -0.6926451 0.008129825 0.9999 Bos taurus sorcin (SRI), mRNA 6717 
TC294544 Bt00005535 -0.6930836 0.034497667 0.9999 
Bos taurus alanyl-tRNA synthetase 2, 
mitochondrial (putative) (AARS2), 
nuclear gene encoding mitochondrial 
protein, mRNA Length=3783  
57505 
TC351653 BLO_ext_00694 -0.6976877 0.00544446 0.9999 MLL  4297 
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TC333673 BLO_ext_00841 -0.7034666 0.00564252 0.9999 4.???  
TC282695 Bt00003954 -0.7067364 0.012119552 0.9999 
Bos taurus exocyst complex 
component 8 (EXOC8), mRNA 149371 
TC278332 Bt00001038 -0.7127656 0.033893797 0.9999 
Bos taurus regulator of G-protein 
signaling 19 (RGS19), mRNA 10287 
TC321922 BLO_ext_01623 -0.7181405 0.025404722 0.9999 
Bos taurus CCAAT/enhancer binding 
protein (C/EBP), delta (CEBPD), 
mRNA  
1052 
TC277480 Bt00005182 -0.7304145 0.006278031 0.9999 
PREDICTED: Bos taurus erbb2 
interacting protein, transcript variant 
2 (ERBB2IP), mRNA  
55914 
TC292630 Bt00005279 -0.7383412 0.03743593 0.9999 
Bos taurus uridine phosphorylase 1 
(UPP1), mRNA 7378 
TC279624 Bt00006409 -0.753558 0.007189578 0.9999 Bos taurus sorting nexin 10 (SNX10), 
mRNA 29887 
TC278443 Bt00002186 -0.7664786 0.026305696 0.9999 
Bos taurus v-fos FBJ murine 
osteosarcoma viral oncogene 
homolog (FOS), mRNA, complete 
cds Length=2097  
2353 
TC276824 Bt00001530 -0.7665316 0.017859635 0.9999 
Bos taurus dual specificity 
phosphatase 1 (DUSP1), mRNA 1843 
TC367459 BLO_ext_00836 -0.7675945 0.007114349 0.9999 
Bos taurus amyloid beta (A4) 
precursor protein-binding, family B, 
member 1 interacting protein 
(APBB1IP), mRNA  
54518 
TC278936 Bt00007536 -0.7687546 0.020227269 0.9999 
Bos taurus ubiquitin-conjugating 
enzyme E2G 2 (UBC7 homolog, 
yeast) (UBE2G2), mRNA, complete 
cds Length=2159  
7327 
TC261637 Bt00003698 -0.7715723 0.007104173 0.9999 
Bos taurus egl nine homolog 2 (C. 
elegans) (EGLN2), mRNA, complete 112398 
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cds Length=1818  
TC265527 Bt00002154 -0.7866212 0.000303215 0.9999 
Bos taurus hemopoietic cell kinase 
(HCK), transcript variant 1, mRNA 
Length=2046  
3055 
TC357443 BLO_ext_00927 -0.7917521 0.004351336 0.9999 
PREDICTED: Bos taurus 
lymphotoxin beta (TNF superfamily, 
member 3) (LTB), mRNA  
4050 
TC334244 BLO_ext_00079 -0.7933595 0.0440944 0.9999 
Bos taurus cDNA clone 
IMAGE:8452392 Length=1216  7326 
TC299298 Bt00006297 -0.8040281 0.025167653 0.9999 
PREDICTED: Bos taurus C2 
calcium-dependent domain containing 
3 (C2CD3), partial mRNA  
26005 
TC290822 Bt00004639 -0.8073241 0.011007653 0.9999 
Bos taurus ubiquitin-conjugating 
enzyme E2G 1 (UBC7 homolog, 
yeast) (UBE2G1) 
7326 
TC263181 Bt00001594 -0.8129252 0.043891789 0.9999 
PREDICTED: Bos taurus regulator of 
G-protein signaling 2-like (RGS2), 
mRNA 
5997 
TC361856 BLO_ext_00349 -0.8144223 0.005791424 0.9999 
Bos taurus Parkinson disease 7 
domain containing 1 (PDDC1) 347862 
TC277688 Bt00004637 -0.8218049 0.003215404 0.9999 
PREDICTED: Bos taurus Rho 
GTPase activating protein 9-like 
(ARHGAP9), mRNA Length=2727 
64333 
3X SSC 3X SSC -0.8222615 0.018442282 0.9999   
3X SSC 3X SSC -0.8351846 0.01818489 0.9999   
TC295250 Bt00006737 -0.8392626 0.045216896 0.9999 Bos taurus vanin 2 (VNN2 8875 
TC310648 BLO_ext_01200 -0.8574485 0.001239908 0.9999 Bos taurus serine dehydratase (SDS) 10993 
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3X SSC 3X SSC -0.888731 0.028668544 0.9999 
  
TC275353 Bt00006525 -0.889815 0.035214426 0.9999 
PREDICTED: Bos taurus N-myc-
interactor-like, transcript variant 2 
(LOC100336259), mRNA 
9111 
TC290705 Bt00005818 -0.8944422 0.020577536 0.9999 
Bos taurus mitochondrial ribosomal 
protein L34 (MRPL34), nuclear gene 
encoding mitochondrial protein, 
mRNA 
64981 
TC275219 Bt00000176 -0.8974086 0.001075358 0.9999 
PREDICTED: Bos taurus eIF4GI 
protein, transcript variant 2 (EIF4GI), 
mRNA  
1981 
TC278835 Bt00003669 -0.8977516 0.020381768 0.9999 
PREDICTED: Bos taurus thioredoxin 
domain containing 17 (TXNDC17),  84817 
TC261047 Bt00005723 -0.9102193 0.038651376 0.9999 
Bos taurus mitochondrial translational 
release factor 1-like (MTRF1L), 
nuclear gene encoding mitochondrial 
protein, mRNA 
54516 
TC278090 Bt00005520 -0.9316696 0.024920119 0.9999 
PREDICTED: Bos taurus solute 
carrier family 40 (iron-regulated 
transporter), member 1-like 
(LOC100335220), mRNA  
30061 
TC277881 Bt00000391 -0.9544988 0.00232998 0.9999 
PREDICTED: Bos taurus 
lymphotoxin beta (TNF superfamily, 
member 3) (LTB), mRNA  
4050 
TC319937 BLO_ext_01352 -0.9784217 0.002317773 0.9999 
Bos taurus fibrinogen-like 2 (FGL2), 
mRNA  10875 
TC368847 BLO_ext_00091 -0.9893231 0.048289121 0.9999 ???  
TC289789 Bt00002906 -0.994158 0.037249807 0.9999 
Bos taurus solute carrier family 39 
(zinc transporter), member 1 
(SLC39A1), mRNA 
27173 
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TC375717 BLO_ext_00404 -0.9951563 0.000509981 0.9999 
Bos taurus uncoupling protein 2 
(mitochondrial, proton carrier) 
(UCP2), nuclear gene encoding 
mitochondrial protein, mRNA  
7351 
TC99448 TC99448 -1.0055053 0.025461097 0.9999 
Bos taurus glucuronidase, beta 
(GUSB), mRNA 2990 
TC343755 BLO_ext_00820 -1.0254509 0.012156463 0.9999 
DCN1, defective in cullin neddylation 
1, domain containing 5 84259 
TC279244 Bt00001997 -1.0421358 0.006543508 0.9999 
Bos taurus 1-acylglycerol-3-
phosphate O-acyltransferase 3 
(AGPAT3), mRNA, incomplete 5' cds 
Length=699 
56894 
TC267945 Bt00006569 -1.043036 0.016981817 0.9999 Bos taurus cytochrome b-561 domain 
containing 1 (CYB561D1), mRNA 284613 
TC290878 Bt00005523 -1.0672874 0.020615908 0.9999 
Bos taurus microtubule associated 
monoxygenase, calponin and LIM 
domain containing 1 (MICAL1), 
mRNA 
64780 
TC375950 BLO_ext_00587 -1.0956933 0.013116818 0.9999 
UP|MK09_HUMAN (P45984) 
Mitogen-activated protein kinase 9 
(Stress-activated protein kinase 
JNK2) (c-Jun N-terminal kinase 2) 
(JNK-55) , partial (80%) 
5601 
TC335505 BLO_ext_01400 -1.102648 0.002014228 0.9999 
Bos taurus ring finger protein 145 
(RNF145), mRNA >gb|BC148080.1| 
Bos taurus ring finger protein 145, 
mRNA (cDNA clone MGC:152141 
IMAGE:8398633), complete cds 
153830 
TC301648 BLO_ext_01747 -1.1347712 0.002939321 0.9999 
Bos taurus DNA fragmentation 
factor, 40kDa, beta polypeptide 
(caspase-activated DNase) (DFFB), 
mRNA 
1677 
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TC99448 TC99448 -1.1724083 0.016557485 0.9999 
Bos taurus glucuronidase, beta 
(GUSB), mRNA 2990 
TC302370 BLO_ext_00125 -1.2355543 0.002240387 0.9999 
Bos taurus v-fos FBJ murine 
osteosarcoma viral oncogene 
homolog (FOS), mRNA, complete 
cds  
2353 
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